DNB QUESTION PAPERS

1)INFORMED CONSENT

 DESCRIBE CONSENT IN ANAESTHESIA PRACTICE INCLUDING ETHICAL AND LEGAL AS-

PECTS (DEC 2010) (2015)
 WHAT ARE THE INGREDIENTS OF PROFESSIONAL NEGLIGENCE? (DEC 2012)
 SIMULATORS IN ANAESTHESIA TRAINING (JUNE 2010). ADVANTAGES AND DISAD-
VANTAGES (2015) CITE SOME EXAMPLES (2014)
 DISCUSS THE ROLE OF EBM IN ANAESTHESIA PRACTICE. QUOTE FEW EXAMPLES(JUNE
2009,2008).
 COMMUNICATION SKILL AND ANAESTHESIOLOGIST (JUNE 2010).
 RECORD KEEPING AND DOCUMENTATION IN ANESTHESIA (2015)

INHALED ANAESTHETICS-DELIVERY SYSTEMS

2)CIRCUITS

 ANAESTHESIA CIRCUIT CLASSIFICATION (2014)

 COAXIAL CIRCUITS(DEC 1998)(JUNE 2002)[PG 27 -RACE 2010]

 DRAW SCHEMATIC DIAGRAMS OF VARIOUS TYPES OF MAPLESON’S BREATHING CIR-

CUITS. GIVE THE FUNCTIONAL ANALYSIS, ADVANTAGES AND DISADVANTAGES OF
BAIN CIRCUIT(JUNE 2010)
 HOW WILL YOU CHECK THE FUNCTIONAL INTEGRITY OF BAIN’S CIRCUIT(JUNE 2011).
(2014) (2015)

3)VAPORIZERS

 CHARACTERISTICS OF IDEAL VAPORIZER(JUNE 2004).

 CLASSIFY VAPORIZERS. BRIEFLY MENTION THE EFFECTS OF ALTERED BAROMETRIC
PRESSURE ON THE PERFORMANCE OF THE VAPORIZERS(JUNE 2008).[PG 15-RACE
2006](2010)

 PHYSICAL PRINCIPLES IN FUNCTIONING OF VAPORIZERS (2016)

 5 DIFFERENCE IN PUMPING AND PRESSURIZING EFFECT ON VAPORIZER , MODIFICA-
TION DONE TO REMOVE THIS EFFECT (2014)

1
4)ANAESTHESIA MACHINE

 DESCRIBE BRIEFLY THE SAFETY FEATURES IN MODERN ANAESTHESIA MACHINES. DIS-

CUSS VARIOUS FEATURES THAT PREVENT THE DELIVERY OF HYPOXIC GAS MIX-
TURES(DEC 2011,2009,2010,2016)
 DESCRIBE THE PRE ANAESTHETIC CHECK LIST FOR ANAESTHESIA MACHINE AND
EQUIPMENT(DEC 2009,2010).
 FUNCTIONAL ANALYSIS OF PRESSURE REDUCING VALVE(JUNE2007)[PG 95-WARDS]
 LINK 25 PROPORTIONING SYSTEM(DEC 2007).[PG 109-110-D &D]
 WHAT ARE THE DIFFERENT TYPES OF CARBON DIOXIDE ABSORBENTS? DESCRIBE THEIR
COMPOSITION. DISCUSS THE ADVANTAGES AND DISADVANTAGES OF EACH(JUNE
2012).
 ROLE OF HUMIDIFICATION IN ANAESTHESIA PRACTICE(DEC 2008). WHAT IS RELATIVE
AND ABSOLUTE HUMIDITY?WHAT ARE ACTIVE AND PASSIVE HUMIDIFIERS?WHAT ARE
THEIR ADVANTAGES AND DISADVANTAGES?(DEC 2012)
 WHAT IS SCAVENGING IN OT?WHAT ARE THE FIVE BASIC PARTS OF A SCAVENGING
SYSTEM?WHAT ARE THE HAZARDS OF A SCAVENGING SYSTEM?(DEC 2012)(2014)
 DISCUSS THE ENVIRONMENTAL HAZARDS IN THE OT AND DISCUSS THE MEASURES FOR
ITS PREVENTION(DEC 2008)(JUNE 2011)(JUNE
2012).[WWW.ACSSURGERY.COM/ACS/CHAPTERS/CH08.HTM]
 WHAT IS LOW FLOW ANAESTHESIA? DISCUSS ITS ADVANTAGES AND DISAD-
VANTAGES(DEC 2006)(JUNE 2011).

5)PULSE OXIMETER

 PULSE OXIMETRY-PRINCIPLES AND APPLICATIONS(DEC 2007).

 RECENT ADVANCES IN PULSE OXIMETRY. BRIEFLY DESCRIBE THE REFLECTANCE AND
MULTIWAVE LENGTH PULSE OXIMETRY. .(2013)

 DISCUSS VARIOUS METHODS OF OXYGEN MONITORING IN ANAESTHESIA PRAC-

TICE(JUNE 2007).[PG 65-RACE 2010]

6)CAPNOGRAPHY

 DISCUSS PRINCIPLES OF MONITORING END TIDAL CO2(JUNE 2007).

 WHAT IS CAPNOGRAPHY?DRAW A NEAT LABELED DIAGRAM OF A NORMAL CAPNO-
GRAPH AND DISCUSS CLINICAL CONSIDERATIONS OF CAPNOGRAPHY(ETCO2 MONI-
TORING)(JUNE2012).

2
7)NEUROMUSCULAR MONITORING

 NEUROMUSCULAR TRANSMISSION WITH THE HELP OF A DIAGRAM. FACTORS THAT IN-

FLUENCE NEUROMUSCULAR TRANSMISSION. (2016)
 INTRAOPERATIVE NEUROMUSCULAR MONITORING(JUNE 2007).
 COMPARE AND CONTRAST TOF AND DOUBLE BURST(DEC 2008).
 WITH THE HELP OF DIAGRAMS, EXPLAIN THE VARIOUS PATTERNS OF NERVE STIMULA-
TION USED FOR NEURO-MUSCULAR (N-M) MONITORING DURING ANAESTHESIA PRAC-
TICE. (2015)(2016)(2011)
 ENUMERATE VARIOUS TECHNIQUES OF MONITORING NEUROMUSCULAR BLOCKADE
DURING ANAESTHESIA. LIST THE ADVANTAGES AND LIMITATIONS OF EACH OF THESE
TECHNIQUES(JUNE 2010,2009).[PG 127-RACE 2010]

8)TEMPERATURE REGULATION & MONITORING

 DESCRIBE IN BRIEF THE SITES AND DEVICES FOR TEMPERATURE MONITORING(DEC

2008).
 CLASSIFY HYPOTHERMIA. DESCRIBE THE PATHOPHYSIOLOGICAL EFFECTS OF HYPO-
THERMIA(JUNE 2012)
 DESCRIBE THERMOREGULATION IN HUMAN BODY, IMPACT OF PERIOPERATIVE HYPO-
THERMIA (2014)
 A) WHY IS AN INFANT MORE PRONE TO HYPOTHERMIA THAN AN ADULT? B) WHAT ARE
THE CONSEQUENCES OF INADVERTENT INTRA-OPERATIVE HYPOTHERMIA IN AN IN-
FANT? C) VARIOUS METHODS OF PREVENTION OF INTRA-OPERATIVE HYPOTHER-
MIA.(2017)

DRUGS

9)IV ANAESTHETICS.

 DECRIBE ALPHA 2 AGONISTS..PHARMACODYNAMICS AND CLINICAL USES OF THEM

 DISCUSS PK AND PD OF CLONIDINE AND ITS ROLE IN CLINICAL PRACTICE ANAESTHE-
SIA AND ICU(JUNE 2011,2007,2008).
 DISCUSS PHARMACOKINETICS AND PHARMACODYNAMICS OF DEXMEDETOMIDINE.
WHAT IS ITS ROLE IN CLINICAL PRACTICE(JUNE 2012,2008,2010,2015).[PG 96-RACE
2011,IJA 2011]

3
  DISSCUSS THE MOA,PD AND PK OF PROPOFOL(DEC 2011) (2015)EFFECT ON VARIOUS
ORGAN SYSTEMS AND CLINICAL USE(2015)

 PROPOFOL INFUSION SYNDROME (2016)

 DESCRIBE THE PHARMACOKINETICS AND PHARMACODYNAMICS OF ETOMI-
DATE.DESCRIBE BRIEFLY ITS ROLE IN CLINICAL PRACTICE(DEC 2010).(2015)
 MENTION THE COMMONLY USED IMMUNOSUPPRESSIVE DRUGS AND THEIR INTERAC-
TION WITH ANAESTHETIC AGENTS(JUNE 2007). [PG 1257-SATISH DESHPANDE]

10)OPIOIDS

 CLASSIFY OPIOIDS. DISCUSS THE MERITS AND DEMERITS OF EPIDURAL FENTANYL AND
MORPHINE(DEC 2011).
 MENTION THE INTRATHECAL AND EPIDURAL OPOIDS IN CLINICAL PRACTICE AND
THEIR COMPLICATIONS(JUNE 2006).MECHANISM OF ACTION (2016)(2007)
 IDEAL OPIOID FOR EPIDURAL USE AND WHY (2017)
 WHAT ARE THE VARIOUS ROUTES OF ADMINISTRATION OF MORPHINE?DISCUSS THE
PHARMACOKINETICS AND PHARMACODYNAMICS OF EPIDURAL MORPHINE(JUNE 2012).

 REMIFENTANYL IN CLINICAL PRACTICE(JUNE 2001) (2016)

 COMPARE FENTANYL AND REMIFENTANYL (2014)

11)IV DRUG DELIVERY SYTEMS .

 WHAT IS TIVA? MATHEMATICAL MODELS COMMONLY USED WITH TARGET CON-

TROLLED INFUSION TCI. BEST INDICATION FOR USE OF TCI.(2014) (DEC 1996)(JUNE
2000)(JUNE 2001)(DEC 2001)(DEC 2003)(JUNE 2006).[PG 41-RACE 2009]
 PCA(DEC 1996)(JUNE 1998)(DEC 1998)(JUNE 2003)(DEC 2004)(DEC 2007).[PG
518,AITKENHEAD][PG 1487-BARASCH]
 WRITE A PRESCRIPTION AND SETTING OF PCA PUMP TO DELIVER MORPHINE FOR PAIN
RELIEF(2014)
 TRANSDERMAL ADMINISTRATION OF DRUGS(JUNE 2008).PRINCIPLES OF TRANSDER-
MAL DRUG DELIVERY WHAT IS EUTECTIC MIXTURE. ADVANTAGES AND DISAD-
VANTAGES OF TRANSDERMAL FENTANYL PATCH(2014)
 CONTEXT SENSITIVE HALF LIFE (2016)

12)PHARMACOLOGY OF MUSCLE RELAXANTS AND ANTAGONISM.

ADVERSE EFFECTS OF NMBA(JUNE 2008).[PG 213-MORGAN 4TH ED]

13)LOCAL ANAESTHETICS

4
  LIPID EMULSION FOR THE TREATMENT OF LOCAL ANAESTHETIC TOXICITY-MECHANISM
AND DOSAGE(JUNE 2008,2010).
 DISCUSS THE CLINICAL MANIFESTATIONS OF LOCAL ANAESTHETIC TOXICITY AND ITS
MANAGEMENT(JUNE 2011). (2015)2012

 PHARMACOKINETICS AND PHARMACODYNAMICS OF ROPIVACAINE. COMPARE ROPI-

VACAINE WITH BUPIVACAINE AND LEVOBUPIVACAINE (2016)
 ANAESTHESIA & NEUROTOXICITY.(2016)
 EFFECT OF ANAESTHETIC AGENTS ON DEVELOPING BRAIN (2017)

14)INHALED ANAESTHETICS-MOA

 DEFINE MINIMUM ALVEOLAR CONCENTRATION.WHAT ARE THE FACTORS AFFECTING

MAC?WHAT IS ITS SIGNIFICANCE IN ANAESTHESIA?(JUNE 2009).[PG 163-MORGAN]
 DISCUSS THE FACTORS WHICH EFFECT THE ALVEOLAR CONCENTRATION OF AN INHA-
LATIONAL AGENT(DEC 2010) (2015).
 DIFFERENT TYPES OF MAC , ROLE OF BLOOD GAS AND OIL GAS SOLUBILITY OF INHA-
LATIONAL AGENTS (2014). (2015)
 CONCENTRATION EFFECT AND SECOND GAS EFFECT PRODUCED DURING UPTAKE OF
INHALATIONAL AGENT(DEC 2007) (DEC 2011). DEFINE FINK EFFECT, (DEC 2011).
 NITROUS OXIDE:CURRENT STATUS(JUNE 2008 JUNE 2011)).[CEACCP 2005 VOL 5
NO.5,IJA 2007,PG 433-ISACON 2009]
 COMPARE AND CONTRAST SEVOFLURANE AND ISOFLURANE(DEC 2008)
 SEVOFLURANE EFFECTS ON VARIOUS ORGAN SYTEMS (2015)
 SEVO VS HALOTHANE (2016)
 NEPHROTOXICITY OF FLUORINATED ANAESTHETICS(DEC 2007).[PG 650-MILLER]
 DESFLURANE , ITS MAC IN O2 AND WITH N20 , ITS VAPORIZER(2017)
 ROLE OF VOLATILE ANAESTHETICS IN ENVIRONMENTAL POLLUTION (2014)

15)RESPIRATORY PHYSIOLOGY.

 DESCRIBE THE OXYGEN HEMOGLOBIN DISSOCIATION CURVE. LEFTWARD AND RIGHT-

WARD SHIFT OF (2014)
 HOW DOES IT DIFFER FROM THE CARBON DIOXIDE DISSOCIATION CURVE?(DEC 2011).

 WHAT ARE BOHR EFFECT AND HALDANE EFFECT? THEIR ROLE IN CARBON DIOXIDE
TRANSPORT IN THE BODY. (2013)
 OXYGEN FLUX (2014) (2017)
 PARTIAL PRESSURE OF OXYGEN AT THE LEVEL OF MITOCHONDRIA(2017)

5
  OXYGEN CASCADE (WITH DIAGRAM) & ITS IMPLICATIONS.(2016)
 DRAW A LABELLED DIAGRAM SHOWING VARIOUS LUNG CAPACITIES AND VOLUMES
(2013)
 DEFINE FRC AND CLOSING VOLUME. DESCRIBE THEIR CLINICAL SIGNIFICANCE (JUN
2011,2008).

 DEFINE AND CLASSIFY DEAD SPACE VENTILATION. DEFINE MINUTE VENTILATION. UN-
DER WHAT CONDITIONS IS MINUTE VENTILATION INCREASED?(JUNE 2012).
 WHAT IS VENTURI PRINCIPLE?DISCUSS ITS APPLICATIONS IN ANAESTHESIA PRAC-
TICE(DEC 2006)(2015,2009)
 DESRIBE BERNOULLI’S PRINCIPLE AND ITS VARIOUS APPLICATIONS IN ANAESTHE-
SIA(JUNE 2012).
 BOYLES LAW, CHARLES LAW (2016)

 DESCRIBE THE METABOLIC FUNCTIONS OF THE LUNG(DEC 2009).

16)RISK OF ANAESTHESIA(ANESTHETIC COMPLICATIONS)

 DISCUSS THE DIFFERENTIAL DIAGNOSIS OF INTROPERATIVE BRONCHOSPASM. HOW

WILL YOU MANAGE IT?(DEC 2011,2012).(PG 111-RACE 2008]

 LARYNGOSPASM DURING ANAESTHESIA(DEC 2007).[YAO,PH 441-ISACON 2009]

 ENUMERATE THE CAUSES AND DIFFERENTIAL DIAGNOSIS OF POST EXTUBATION
LARYNGOSPASM. HOW WILL YOU MANAGE IT(DEC 2011) (2016)
 POST EXTUBATION STRIDOR (2014)

 WHAT IS POSTOPERATIVE JAUNDICE? DESCRIBE ITS CAUSE(DEC 2010)

 ENUMERATE THE RISK FACTORS FOR PONV.DISCUSS MEASURES TO PREVENT AND ITS
MANAGEMENT(JUNE 2009,2006,2008,2010).[PG 1005-MORGAN 4TH ED]
 DESCRIBE POST OP COGNITIVE DYSFUNCTION(POCD). METHODS TO DETECT IT IN CLIN-
ICAL PRACTICE. .(2013)
 CAUSES, IMPLICATIONS AND MANAGEMENT OF POST ANAESTHETIC SHIVERING(DEC
2006)(JUNE 2011).(2015)(2008, 2009)(2010)

17)DELAYED RECOVERY

 WHAT ARE THE POTENTIAL CAUSES OF DELAYED RESUMPTION OF SPONTANEOUS RE-

COVERY AFTER ABDOMINAL SURGERY WITH GENERAL ANAESTHESIA. DISCUSS THE
PROBLEMS, ITS DIAGNOSIS AND MANAGEMENT(JUNE 2005,2004,2009,2006).[PG 112-
RACE 2002]

6
  DISCUSS THE CAUSES OF DELAYED RECOVERY FOLLOWING GA IN ELDERLY(DEC 2008).
(2014)
 ENHANCED RECOVERY AFTER SX (2017)

18)DESATURATION

 DISCUSS THE DISTRIBUTION OF VENTILATION AND PERFUSION IN A NORMAL LUNG

WITH THE HELP OF A LABELED DIAGRAM. WHAT ARE THE FACTORS AFFECTING VEN-
TILATION PERFUSION RATIO?(JUNE 2009).
 HPV(JUNE 2005)(JUNE 2009). [PG 1054-BARASCH 6TH ED, PG 29-RACE 2009]
 WHAT ARE THE MAJOR CAUSES OF HYPOXEMIA?WHAT IS HPV?HOW CAN GA WORSEN
V/Q MISMATCH(DEC 2010, 2005.2009)
 CAUSES OF IMPAIRMENT OF RESPIRATORY FUNCTION UNDER ANAESTHESIA. INTER-
VENTIONS DURING ANAESTHESIA TO PREVENT ATELECTASIS.(2013)
 MANAGEMENT OF A PATIENT WHO IS NOT MAINTAINING OXYGEN SATURATION AFTER
AN ELECTIVE ABDOMINAL SURGERY(DEC 2005).
 LIST THE VARIOUS CAUSES OF REDUCED ARTERIAL OXYGEN TENSION IN THE IN-
TRAOPERATIVE PERIOD AND OUTLINE THEIR MANAGEMENT(JUNE 2010). (2014)
 A 30 YEAR OLD FEMALE ASA GRADE 1 FOLLOWING EXPLORATORY LAPAROTOMY IS
NOT MAINTAINING OXYGEN SATURATION IN THE POSTOP PERIOD. DISCUSS ITS CAUS-
ES AND MANAGEMENT(JUNE 2011).

 CAUSES AND MANAGEMENT OF POSTOPERATIVE HYPOXEMIA(DEC 2006).

 WHAT ARE THE FACTORS LEADING TO ARTERIAL HYPOXEMIA IN THE PACU?DISCUSS
THE DIFFERENTIAL DIAGNOSIS(DEC 2012)

19)ANAPHYLAXIS(ANAPHYLACTOID) REACTIONS

 DISCUSS THE PATHOPHYSIOLOGY AND MANAGEMENT OF ANAPHYLACTOID REAC-

TIONS IN ANAESTHESIA(JUNE 2001)(DEC 2001).
 CLINICAL MANIFESTATIONS AND MANAGEMENT OF A PATIENT WITH ACUTE ANAPHY-
LAXIS(JUNE 2010).(2011).
 ENUMERATE THE AGENTS IMPLICATED IN ALLERGIC REACTIONS DURING ANAESTHE-
SIA. HOW WOULD YOU MANAGE A PATIENT WITH ANAPHYLAXIS DURING ANAESTHE-
SIA?(DEC 2012)(2014)

20)MONITORED ANAESTHESIA CARE AND DAY CARE SX

7
  MONITORED ANAESTHESIA CARE(JUNE 1997).**(DEC 2007).(JUNE 1998).[PG65-RACE
2008]
 MONITORED ANAESTHESIA CARE IN 80 YEARS OLD MAN WITH IHD FOR CATARACT
SURGERY(DEC 2004)(2000)(2008)(2009).[PG 65-RACE 2008]
 WHAT IS MONITORED ANAESTHESIA CARE?DISCUSS THE DISCHARGE CRITERIA FOR A
PATIENT AFTER DAY CARE SURGERY.(JUNE 2009) (DEC 2003)(DEC 2004)(DEC 2006)..
 WHAT IS MONITORED ANAESTHESIA CARE?DESCRIBE MINIMUM MONITORING STAND-
ARDS FOR A PATIENT UNDERGOING MONITORED ANAESTHESIA CARE(DEC 2011)
(2017).
 DEFINE MONITORED ANAESTHESIA CARE.DISCUSS ITS GOALS AND TECHNIQUES(JUNE
2012)[EORCAPS 2012] .ADVANTAGES AND DISADVANTAGES(2013)

 WHAT IS “FAST TRACKING CONCEPT” AFTER AMBULATORY ANAESTHESIA? ENUMER-

ATE THE CRITERIA USED TO DETERMINE FAST TRACK ELIGIBILITY AFTER AMBULATO-
RY ANAESTHESIA (2015)
 RA IN DAY CARE SURGERY(JUNE 2006)(JUNE 2007,2010).[PG 2435-MILLER]
 ANAESTHESIA FOR DCS(JUNE 1999)(JUNE 2001)(DEC 2001)(JUNE 2002)[IJA 2005]
 DESCRIBE THE CRITERIA FOR SELECTION OF ANAESTHETIC AGENTS FOR USE IN DCS.
ENUMERATE THE AGENTS OF YOUR CHOICE WITH REASONS(DEC 2009).
 WHAT ARE THE ANAESTHETIC CONSIDERATIONS FOR DCS? DISCUSS THE CLINICAL
CRITERIA FOR RECOVERY AND DISCHARGE AFTER DAY CARE SURGERY(JUNE 2012)
 DESCRIBE VARIOUS DRUGS USED FOR PREMEDICATION IN DAY CARE SX WITH THEIR
ROLES. .(2013)

21) PACU.

 PLANNING OF PACU(JUNE 2008).[PG 1002-MORGAN 4TH ED]

 DESCRIBE THE TECHNIQUES OF CHEST PHYSIOTHERAPY?WHAT IS ITS ROLE IN THE
POST SURGICAL PERIOD(JUNE 2009).
 WHAT ARE THE CRITERIA FOR DISCHARGE FROM PACU?(DEC 2010).

22) MONITORING DEPTH OF ANAESTHESIA.

 WHAT IS BIS MONITORING?WHAT ARE ITS CLINICAL APPLICATIONS IN ANAESTHESIA

PRACTICE?(DEC 2008,2010).
 AWARENESS UNDER ANAESTHESIA(1996-2000)[PG 66-RACE 2006,IJA 2009]
 AWARENESS AND WAKEFULNESS UNDER ANAESTHESIA(JUNE 1999)(DEC 1994)[PG 148-
157-IJA 2009] .COMPLICATIONS OF AWARENESS (2013)

8
  DISCUSS THE PHARMACOLOGICAL PRINCIPLES OF MEASURING THE DEPTH OF ANAES-
THESIA AND TECHNIQUES FOR MONITORING THE DEPTH OF ANAESTHESIA(JUNE 2002
JUNE 2006). .(2013)).

23) CARDIOVASCULAR MONITORING

 DESCRIBE THE ANATOMY OF IJV WITH THE HELP OF A DIAGRAM. DISCUSS ANY ONE
APPROACH FOR IJV CANNULATION(DEC 2011,2007) DESCRIBE THE TECHNIQUE AND
COMPLICATIONS OF IJV CANNULATION(JUNE 2012).

 VARIOUS APPROACHES FOR CVP MONITORING AND FLUID CHALLENGE TEST USING
CVP MONITORING (2015)
 CVP WAVEFORMS AND THEIR CORRELATION WITH ECG WITH THE HELP OF A DIA-
GRAM.
 DIAGNOSTIC SIGNIFICANCE OF CVP WAVEFORM. (2015)

24) CARDIAC OUTPUT MONITORING

 WHAT ARE THE DETERMINANTS OF CARDIAC OUTPUT AND DISCUSS VARIOUS NON-
INVASIVE METHODS OF MEASUREMENT OF CARDIAC OUTPUT(DEC 2006)

 PULMONARY ARTERY PRESSURE MONITORING(JUNE 2006).

 FLUID RESPONSIVENESS , VARIOUS STATIC AND DYNAMIC INDICES OF FLUID RESPON-
SIVENESS (2016)
 DESCRIBE THE INDICATIONS,CONTRAINDICATIONS AND COMPLICATIONS OF INVASIVE
ARTERIAL BLOOD PRESSURE MONITORING. DESCRIBE THE TECHNIQUE(DEC 2009).[PG
123-MORGAN]
 A PATIENT DEVELOPS GANGRENE OF THE FINGERS AFTER RIGHT RADIAL ARTERY CAN-
NULATION. A) WHAT CAN BE THE POSSIBLE EXPLANATION FOR THIS? B) MODIFIED AL-
LEN’S TEST AND ITS INTERPRETATION. C) WHAT ARE THE OTHER COMPLICATIONS/
SIDE EFFECTS OF RADIAL ARTERY CANNULATIONS?(2017)

25) TEE AND USG

 TEE IN ANAESTHESIA PRACTICE(JUNE 2008,2011).[RACE 2011]

 TEE ROLE IN HEMODYNAMIC MONITORING (2013)
 DESCRIBE THE ROLE OF INTRAOPERATIVE ECHOCARDIOGRAPHY IN CLINICAL ANAES-
THESIA(DEC 2009).

9
  USG->PRINCIPLES AND ITS USES IN DAY TO DAY PRACTICE OF ANAESTHESIA(JUNE
2010) (2017).
 HOW IS USG USEFUL IN ANAESTHESIA AND INTENSIVE CARE MEDICINE AND EXPLAIN
THE USEFULNESS OF TEE DURING CARDIAC SURGERY(DEC 2005).USHG PHYSICS IN-
VOLVED (2015) [IJA 2007](2014)

ANAESTHESIA MANAGEMENT

26) PREOPERATIVE EVALUATION.

 ASA PHYSICAL STATUS CLASSIFICATION FOR PREOPERATIVE ANAESTHETIC RISK AS-

SESSMENT(JUNE 2010). (2014)
 OTHER FACTORS THAT MAY ALTER THE RISK A/W NAESTHESIA(2013)
 WHAT ARE THE GOALS OF PRE-ANAESTHETIC CHECK UP?ASA RISKS GRADING AND
FASTING GUIDELINES(DEC 2011).[PG 1002 MILLER 7 TH ED]

27) ANS AND DIABETES

 CLINICAL TESTS FOR EVALUATION OF AUTONOMIC NERVOUS SYSTEM(JUNE 2008).[PG

295-MILLER 7TH ED] (2012) (2016)
 DIABETIC PATIENT WITH AUTONOMIC NEUROPATHY FOR TAH(JUNE 2006).

 A 50 YEAR OLD MALE AND KNOWN DIABETIC IS SCHEDULED FOR UPPER ABDOMINAL
SURGERY. HOW WILL YOU EVALUATE THE ANS?(DEC 2009(2012).
 W.H.O. DIAGNOSTIC CRITERIA FOR DIABETES MELLITUS.(2015)
 ANAESTHETIC MANAGEMENT OF A CASE OF DM SCHEDULED FOR OPEN CHOLECYS-
TECTOMY (DEC 2005).
 DISCUSS THE ANAESTHETIC MANAGEMENT OF AN INADEQUATELY MANAGED DIABE-
TES MELLITUS PATIENT WITH KETOACIDOSIS POSTED FOR BKA(JUNE 2007,2016).[PG
1300 BARASCH]
 DESCRIBE THE DIFFERENT METHODS USED FOR PERIOPERATIVE CONTROL OF BLOOD
SUGAR IN DIABETIC PATIENTS UNDERGOING MAJOR ABDOMINAL SURGERY WITH
THEIR ADVANTAGES AND DISADVANTAGES(DEC 2009).[PG 782-YAO]

28) CNS
 ENUMERATE THE FACTORS REGULATING CBF AND THE EFFECT OF VARIOUS ANAES-
THETIC DRUGS ON CBF (JUNE 2010,2009,2008)[PG25-RACE 2008]
 BLOOD SUPPLY BRAIN , WHAT IS CPP , FACTORS AFFECTING IT (2014)

10
 WHAT IS CEREBRAL PROTECTION?EXPLAIN THE METHODS ADOPTED IN CLINICAL
PRACTICE FOR CEREBRAL PROTECTION(JUNE 2005)
 DISCUSS THE REGULATION OF ICT AND METHODS AVAILABLE FOR REDUCING IT UN-
DER ANAESTHESIA(DEC 1994) (JUNE 2012)..
 DESCRIBE THE REGULATION OF ICP AND WHAT ARE THE PATHOPHYSIOLOGICAL IN-
SULTS WHICH EXACERBATE THE PRIMARY BRAIN INJURY FOLLOWING HEAD TRAU-
MA?HOW CAN THESE EFFECTS BE REDUCED?(DEC 2010).
 WHAT ARE THE INDICATIONS FOR ICP MONITORING IN PATIENTS WITH HEAD INJU-
RY?DESCRIBE THE ICU MANAGEMENT STRATEGIES OF A PATIENT WITH SEVERE HEAD
INJURY?(DEC 2012,2001,2009). METHODS AVAILABLE FOR REDUCING THE PRESSURE
UNDER ANAESTHESIA(JUNE 2007).
 INDICATIONS AND ADVANTAGES OF PERIOPERATIVE USE OF TRANSSCRANIAL DOP-
PLER MONITORING. HOW DO WE MEASURE CBF WITH TCD (2014)
 A 20 YEAR OLD FEMALE WITH MASS IN POSTERIOR CRANIAL FOSSA IS SCHEDULED FOR
CRANIOTOMY. DESCRIBE THE ANAESTHETIC MANAGEMENT(DEC 2009 JUNE 2004)
.(2013,2011).[PG 205-RACE 2011]

 DESCRIBE ANAESTHETIC AND POSTOPERATIVE MANAGEMENT OF A PATIENT UNDER-

GOING INTRA-CRANIAL ANEURYSM SURGERY(DEC 1996).[PG 385-ISACON 2009] (2016)
 DISCUSS THE PERIOPERATIVE MANAGEMENT OF CEREBRAL AVM(DEC 2005) (2013)
 TYPES OF HYDROCEPHALUS , MANAGEMENT OF A CHILD 2 YR OLD FOR VP
SHUNT(2014,2002(JUNE 2012)
 ANAESTHETIC MANAGEMENT OF A CASE OF PITUITARY ADENOMA FOR TRANSPHE-
NOIDAL HYPOPHYSECTOMY.(JUNE 2006). ANAESTHETIC CONSIDERATIONS AND MAN-
AGEMENT OF POST OP COMPLICATIONS (2015).
 A 25 YEARS OLD MAN PRESENTS WITH MARKED FEATURES OF ACROMEGALY AND IS
POSTED FOR TRANSPHENOIDAL HYPOPHYSECTOMY.DISCUSS THE ANAESTHETIC MAN-
AGEMENT(DEC 2007).[EORCAPS-2011]
 INTRAOPERATIVE PROBLEMS OF NEUROSURGICAL PROCEDURES UNDER ANAESTHESIA
IN SITTING POSITION(JUNE2007).
 DESCRIBE THE COMPLICATIONS ASSOCIATED WITH SITTING POSITION DURING POSTE-
RIOR FOSSA SURGERY AND THEIR MANAGEMENT(DEC 2010).”(2015)
 ENUMERATE VARIOUS POSITIONS USED FOR SURGICAL APPROACH OF INFRATENTORI-
AL TUMOURS .(2015)
 ANAESTHETIC EVALUATION AND MANAGEMENT OF A NEONATE WITH MENINGOMYE-
LOCOELE SCHEDULED FOR CORRECTIVE SURGERY.

11
  INDICATIONS AND TECHNIQUE OF AWAKE CRANIOTOMY . 3 MOST PREFERRED DRUGS
USED IN THESE PTS (2014)WHAT ALL PARAMETERS ARE MONITORED(2017)
 GCS(JUNE 1996)(JUNE 2002)(DEC 2002)(DEC 2006). (2015)ITS ROLE IN CLASSIFYING
TRAUMATIC BRAIN INJURY(2015) HOW WILL YOU MANAGE THIS PATIENT IN THE
EMERGENCY DEPARTMENT? (2015)

29) PATIENT POSITIONING.

 DISCUSS THE ANAESTHETIC PROBLEMS OF SURGERY IN PRONE POSITION(JUNE

2011).GIVE AN ACCOUNT OF POSITIVE PRESSURE VENTILATION IN THIS POSI-
TION.(2014)
 VARIOUS PATIENT POSITIONS DURING ANAESTHESIA AND THEIR COMPLICA-
TIONS.(2015)
 VARIOUS INDICATIONS AND DISADVANTAGES OF TRENDELENBERG’S POSITION DUR-
ING ANAESTHESIA AND SURGERY. HOW CAN THESE BE PREVENTED?(2016)

30) HTN

 DEFINE PERIOPERATIVE HYPERTENSION. DESCRIBE THE CAUSES AND MANAGE-

MENT(DEC 2005).
 WHAT ARE THE CAUSES OF INTRA-OPERATIVE HYPERTENSION IN A PREVIOUSLY NOR-
MOTENSIVE PATIENT? DISCUSS VARIOUS MODALITIES TO MANAGE IT
(2011)(2015,2006)
 ANAESTHETIC CONCERNS IN A PATIENT WITH UNCONTROLLED HYPERTENSION IN THE
PERIOPERATIVE PERIOD, COMPLICATIONS AND DRUG INTERACTIONS OF THESE DRUGS
(2014)
 CLASSIFY ANTIHYPERTENSIVE DRUGS. DESCRIBE THE MANAGEMENT OF HYPERTENSIVE
EMERGENCY(DEC 2009,2010).[PG 448-451-MORGAN,PG 301-ISACON 2009] PERIOPERA-
TIVE BETA BLOCKER THERAPY(DEC 2007).[PG 597-ISACON 2009]

 CLASSIFY ACUTE HYPERTENSIVE EPISODES. DISCUSS THE PRINCIPLES OF MANAGEMENT

AND DRUGS USED IN THE MGT OF HYPERTENSIVE EMERGENCY. .(2013)
 COMPARE AND CONTRAST NTG AND NITROPRUSSIDE, THEIR CLINICAL APPLICATIONS
(2015) (2016)
 COMPARE AND CONTRAST DOPAMINE AND DOBUTAMINE AS AN INOTROPIC
AGENT(DEC 2006,2009).
 ANAESTHETIC MANAGEMENT OF A CASE OF ESSENTIAL HYPERTENSION SCHEDULED
FOR UPPER ABDOMINAL SURGERY(JUNE 2005)

12
  A 70 YEAR OLD HYPERTENSIVE MAN WITH CAD IS SCHEDULED FOR TURP.DISCUSS THE
ANAESTHETIC MANAGEMENT(DEC 2007).
 A 40 YEAR OLD MAN WEIGHING 140 KG HAS DM AND HTN AND IS SCHEDULED FOR
GASTRIC BANDING.DISCUSS THE ANAESTHETIC MANAGEMENT(DEC 2007).
 A 35 YEAR OLD HYPERTENSIVE PATIENT WITH CHRONIC CHOLECYSTITIS IS SCHED-
ULED FOR LAPAROSCOPIC CHOLECYSTECTOMY.OUTLINE THE PRE-OPERATIVE EVALU-
ATION, PREPARATION AND ANAESTHETIC MANAGEMENT OF THIS PATIENT (JUNE
2010).
 DISCUSS THE PREOPERATIVE EVALUATION AND ANAESTHETIC MANAGEMENT OF 70
YEAR OLD HYPERTENSIVE PATIENT FOR TOTAL LARYNGECTOMY(JUNE 2012)

31) LIVER DISEASE

 DISCUSS SYNTHETIC FUNCTIONS OF THE LIVER.(2011) (2014)

 WHAT IS THE ROLE OF ALBUMIN IN PHARMACOKINETICS?(JUNE 2011).
 ASSESSMENT OF RISK FACTORS FOR PATIENT WITH MODERATE TO SEVERE LIVER DIS-
EASE(DEC 2001).[RACE 2011]
 PREOPERATIVE PREPARATION AND SURGICAL RISK ASSESSMENT IN A PATIENT WITH
CIRRHOSIS OF LIVER(JUNE 2000).[PG 1269-1271-BARASCH]

 ANAESTHETIC CONSIDERATIONS IN CHRONIC LIVER FAILURE(DEC 2005) . ENUMERATE

THE FUNCTIONS OF LIVER.DISCUSS THE ANAESTHETIC IMPLICATIONS IN A PATIENT
WITH CIRRHOSIS AND ASCITES(DEC 2011) (2014)
 A PATIENT WITH OBSTRUCTIVE JAUNDICE(SERUM BILIRUBIN 20 MG%) IS POSTED FOR
WHIPPLE’S PROCEDURE.DISCUSS PREOPERATIVE EVALUATION AND ANAESTHETIC
MANAGEMENT OF THIS CASE(DEC 2006).
 DESCRIBE THE RISK STRATIFICATION OF A PATIENT WITH DERANGED LIVER FUNC-
TIONS SCHEDULED FOR PARTIAL LIVER RESECTION(DEC 2009). (2016)

32) HEPATO RENAL SYNDROME

 DISCUSS THE DIAGNOSIS,PATHO-PHYSIOLOGY ,TREATMENT OF HEPATORENAL SYN-

DROME.WHAT ARE THE MEASURES TO PREVENT IT?(JUNE 2009,2012). (2017)
 PREOP EVALUATION AND MGT OF ONE MONTH OLD CHILD WITH BILIARY ATRESIA
POSTED FOR LAPAROTOMY AND REPAIR (2013)

33) LIENO -RENAL SHUNT

13
  PRE ANAESTHETIC EVALUATION AND PREPARATION OF A PATIENT WITH PORTAL HY-
PERTENSION FOR LENO RENAL SHUNT(JUNE 2007)[IJA 2007]
 WRITE PREOPERATIVE EVALUATION AND PREPARATION OF A PATIENT WITH PORTAL
HTN SCHEDULED FOR L-R SHUNT(JUNE 2008,2004,2007,2009,2010).[PG 42-RACE
2010,PG 363-RACE 2011 PG 265-270-STOELTING]]

34) ANAESTHESIA FOR RENAL AND GUT

 TURP SYNDROME(DEC 2000).[PG 359-RACE 2012] (2013)

 DESCRIBE CLINICAL PRESENTATION,PATHOPHYSIOLOGY AND MANAGEMENT OF TURP
SYNDROME(JUNE 2011) (2015)
 DISCUSS THE PRE-OPERATIVE EVALUATION AND ANAESTEHTIC MANAGEMENT OF AN
80 YEAR OLD PATIENT WITH CARDIAC PACEMAKER FOR TURP(DEC 2011 JUNE 2010)).

35) RENAL TRANSPLANT

 A 35 YEAR OLD PATIENT OF CHRONIC RENAL FAILURE IS SCHEDULED FOR RENAL

TRANSPLANT.DISCUSS THE ANAESTHETIC MANAGEMENT(DEC 2006).
 DISCUSS THE PREOPERATIVE EVALUATION,PREPARATION AND ANAESTHETIC MAN-
AGEMENT OF A PATIENT WITH TRANSPLANTED KIDNEY PRESENTING FOR INCIDENTAL
ELECTIVE SURGERY(JUNE 2011).(2008)
 ANAESTHESIA IN A PT WITH END STAGE KIDNEY DISEASE (2014)
 ANESTHETIC CONCERNS FOR ORGAN TRANSPLANTED PATIENT.(2017)

36)RRT.
 WHAT ARE THE PROBLEMS RELATED TO CHRONIC HEMODIALYSIS(JUNE 2008).
 WHAT ARE THE INDICATIONS FOR RRT?LIST DIFFERENT MODES OF RRT. DISCUSS THE
ROLE OF CRRT IN SEPTIC SHOCK(DEC 2010,2012).
 HEMO VS PERITONEAL DIALYSIS (2014)
 DESCRIBE ROLE OF RRT IN MODS(DEC 2012).

37) PERIOPERATIVE ACID-BASE BALANCE

 WHAT ARE THE MAJOR BUFFER SYSTEMS IN THE BODY? ENUMERATE THE CAUSES, EF-
FECTS AND MANAGEMENT OF METABOLIC ACIDOSIS(DEC 2009).[PG 716-MORGAN]
(2015)
 WHAT IS ANION GAP? DESCRIBE THE CAUSES AND MANAGEMENT OF METABOLIC ACI-
DOSIS FROM LOW CARDIAC OUTPUT(DEC 2012).

14
  DEFINE BASE EXCESS/DEFICIT .HOW DO KIDNEYS COMPENSATE FOR ACID BASE BAL-
ANCE?(JUNE 2011) (DEC 2004)(JUNE 2006).. [PG 712 –MORGAN 4 TH
ED] (2016)
 DESCRIBE THE COUNTERCURRENT MECHANISM IN THE KIDNEY.DISCUSS THE RENAL
PROTECTION STRATEGIES DURING PERIOPERATIVE PERIOD(JUNE 2012).

38) COPD
 WHAT IS CHRONIC OBSTRUCTIVE PULMONARY DISEASE? HOW WILL YOU MANAGE OX-
YGENATION AND PAIN IN POST OPERATIVE PERIOD OF A CASE OF COPD UNDERGOING
UPPER ABDOMINAL SURGERY?(DEC 2012)
 HOW WILL YOU EVALUATE A PATIENT WITH OSA POSTED FOR LAPAROTOMY, DE-
SCRIBE PREOPERATIVE PREPARATION IN SUCH PATIENTS. .(2013)

 BEDSIDE PFT’S(JUNE 2010).

 DISCUSS THE ANAESTHETIC MANAGEMENT OF A 20 YEAR OLD MALE WITH
ACHALASIA CARDIA AND BRONCHIAL ASTHMA FOR LAPAROSCOPIC CARDIO-
MYOTOMY(JUNE 2007).
 PREOP EVALUATION AND PREPARATION OF 36 YEARS OLD ASTHMATIC FEMALE
SCHEDULED FOR LAPAROSCOPIC CHOLECYSTECTOMY(JUNE 2008).(2013)

39) SMOKING

 ENUMERATE THE EFFECTS OF CHRONIC SMOKING AND THE ANAESTHETIC IMPLICA-

TIONS(DEC 2008,2009,2010).

40) PFT’S

 RELEVANCE OF PFT’S(DEC 2000).[PG 153-RACE 2009]

 DESCRIBE WITH DIAGRAM THE FLOW VOLUME LOOPS IN:
(A)HEALTHY ADULT
(B)PATIENT WITH RESTRICTIVE LUNG DISEASE
(C)PATIENT WITH OBSTRUCTIVE LUNG DISEASE(JUNE 2009).[PG 8-YAO]
 DRAW A DIAGRAM TO SHOW VARIOUS LUNG VOLUMES AND CAPACITIES.DESCRIBE
THE SPIROMETRY FEATURES OF PATIENTS WITH OBSTRUCTIVE AND RESTRICTIVE
PULMONARY DISORDER(DEC 2010) (2016)

41) ANAESTHESIA FOR THORACIC SURGERY

15
  WHAT ARE THE INDICATIONS FOR OLV?DISCUSS THE VENTILATORY MANAGEMENT
DURING ONE LUNG ANAESTHESIA(DEC 2006,2004,2009). [PG 589-MORGAN 4TH ED]
 MANAGEMENT OF SEVERE HYPOXAEMIA DURING ONE LUNG VENTILATION.(2016)

42) PNEUMONECTOMY

 DISCUSS THE ANAESTHETIC MANAGEMENT OF A PATIENT POSTED FOR PNEUMONEC-

TOMY CA RIGHT BRONCHUS-PREPARATION AND MANAGEMENT(JUNE 2004).
 DISCUSS THE PRE-OPERATIVE EVALUATION AND PREPARATION OF A 55 YEAR OLD
MALE WITH BRONCHIECTASIS SCHEDULED FOR RIGHT LOWER LOBE EXCISION(DEC
2010).BRIEFLY ENUMERATE THE POSTOPERATIVE COMPLICATIONS(JUNE 2012). (2015)
POST THORACOTOMY COMPLICATIONS(2017)
 ANAESTHESIA FOR DRAINAGE OF EMPYEMA THORACIS(JUNE 2000).[PG 372-OHA]
 ANAESTHETIC CONSIDERATION FOR PATIENT WITH BPF FOR REPAIR(DEC 2005,2002).
 HYDROPNEUMOTHORAX(JUNE 2003).
 OPEN PNEUMOTHORAX . DESCRIBE AND ILLUSTRATE 2 BOTTLE SYSTEMS (2014)
 WRITE THE INDICATIONS OF MEDIASTINOSCOPY?WRITE THE ANAESTHETIC IMPLICA-
TIONS OF MEDIASTINOSCOPY(JUNE 2008).[CEACCP 2007][MORGAN 607]
 A 40 YEAR OLD MALE WITH EMPHYSEMATOUS BULLAE IN RIGHT LUNG IS SCHEDULED
FOR THORACOSCOPIC EXCISION OF BULLA(VATS).DESCRIBE THE ANAESTHETIC MAN-
AGEMENT(DEC 2009).

43) ESOPHAGECTOMY

 PREOPERATIVE ASSESSMENT,PREPARATION SPECIFIC TO THORACO ABDOMINAL

ESOPHAGECTOMY.DESCRIBE YOUR ANAESTHETIC PROBLEM DURING OPERATION(JUNE
2005). [PG 379-OHA],[PG 609-MORGAN]
 A 68 YEAR OLD MALE WITH CARCINOMA ESOPHAGUS IS POSTED FOR TOTAL ESOPH-
AGECTOMY AND GASTRIC PULL UP.DESCRIBE THE PREOPERATIVE PREPARA-
TION,EVALUATION AND ANAESTHETIC MANAGEMENT(JUNE 2011,2010).

44) PHEOCHROMOCYTOMA:-

 DISCUSS THE PRE ANAESTHETIC PREPARATION,ANAESTHETIC GOALS AND IN-

TRAOPERATIVE MANAGEMENT OF A 30 YEAR OLD FEMALE PATIENT WITH DIAGNOSIS

16
 OF PHEOCHROMOCYTOMA SCHEDULED FOR EXCISION OF ADRENAL TUMOR(JUNE
2011). (2015)2006.

45) THYROID

 PREOPERATIVE EVALUATION, PREPARATION AND ANAESTHETIC MANAGEMENT OF A

PATIENT WITH MULTINODULAR GOITRE WITH RETROSTERNAL EXTENSION. (2015)
(2014)
 DESCRIBE THE CLINICAL FEATURES OF HYPOTHYROIDISM.DISCUSS THE ANAESTHETIC
CONSIDERATION IN A HYPOTHYROID PATIENT SCHEDULED FOR UPPER ABDOMINAL
SURGERY(DEC 2011,2008)
 DESCRIBE THE MANIFESTATIONS AND MANAGEMENT OF THYROID STORM IN-
TRAOPERATIVELY. DESCRIBE THE MANAGEMENT OF SUCH A CASE(DEC
2009,2008,2009).
 THYROTOXIC PATIENT FOR SUBTOTAL THYROIDECTOMY(JUNE 2006).
 CAUSES OF AIRWAY OBSTRUCTION FOLLOWING THYROID SURGERY AND ITS MAN-
AGEMENT(JUNE 2003).
 DISCUSS PREOPERATIVE EVALUATION AND ANAESTHETIC MANAGEMENT OF A 40
YEAR OLD HYPERTHYROID PATIENT POSTED FOR TOTAL THYROIDECTOMY. ENUMER-
ATE POSTOPERATIVE COMPLICATIONS(JUNE 2012).
 PATIENT UNCONTROLLED THYROID POSTED FOR EMERGENCY SX , CONCERNS AND
MGT(2013)
 ENUMERATE THE NS OF LARYNX. ENUMERATE THE SIGNS AND SYMPTOMS OF BILAT-
ERAL RECURRENT LARYNGEAL NERVE PALSY FOLLOWING TOTAL THYROIDECTO-
MY(DEC 2009,2012).
 DESCRIBE THE ANATOMY OF LARYNX AND ITS INNERVATIONS. WHAT ARE THE DIF-
FERENCES BETWEEN NEONATAL AND ADULT LARYNX?(JUNE 2012).

46) CARCINOID TUMOR

 A 30 YEAR OLD WOMAN IS SCHEDULED FOR REMOVAL OF CARCINOID TUMOR.WRITE

THE ANAESTHETIC MANAGEMENT(JUNE 2008).[PG 172-OXFORD HANDBOOK OF AN-
AESTHESIA]

47) CUSHING’S SYNDROME

17
  DISCUSS THE ANAESTHETIC MANAGEMENT OF A 25 YEARS OLD FEMALE WITH CUSH-
ING’S SYNDROME FOR BILATERAL ADRENALECTOMY(JUNE 2007,2009).[PG 395-
STOELTING]

48) NEUROMUSCULAR DISORDERS AND MALIGNANT HYPERTHERMIA

 WHAT IS MYASTHENIA GRAVIS?WHAT ARE ITS CLINICAL FEATURES?DISCUSS THE PRE-

OPERATIVE INVESTIGATIONS, PREPARATION, ANAESTHETIC MANAGEMENT OF SUCH A
CASE PRESENTING FOR INTERVAL APPENDICECTOMY AND MANAGEMENT OF THE
LIKELY COMPLICATIONS.(JUNE 1998) [PG 818-MORGAN,P 69-RACE 2001,PG 109-RACE
2005,RACE 2011] (2016)
 WHAT ARE THE ANAESTHETIC CONCERNS IN THE MANAGEMENT OF A PATIENT WITH
MYASTHENIA GRAVIS SCHEDULED FOR THORACOSCOPIC THYMECTOMY(DEC 2012).
 TEMPERATURE REGULATION IN ADULTS, PREDISPOSING FACTORS, DIAGNOSIS AND
MANAGEMENT OF MH(JUNE 2005,2010,2012).
 MYASTHENIA GRAVIS VS MYASTHENIC SYNDROME

49 ) PARKINSON’S DISEASE

 PRE-OP EVALUATION AND ANAESTHETIC CONSIDERATIONS OF A PATIENT WITH PAR-

KINSON’ DISEASE(JUNE 2008)(DEC 2008).[PG 227-STOELTING,PG 650 MORGAN,IJA
2007,PG 630-BARASCH]

50 )AIRWAY MANAGEMENT IN THE ADULT

 SUPRA GLOTTIC AIRWAY DEVICES(DEC 2007). [PG 85-RACE 2009,PG 633-OAR]

 CLASSIFICATION , MODIFICATION DONE IN 3RD GENERATION SGA
 COMPLICATIONS ASSOCIATED WITH SGA (2014)
 METHODS FOR CLEANING AND STERLIZATION OF THESE(2016)
 I-GEL AIRWAY(JUNE 2008)(JUNE 2010).[IJA 2009]
 ENUMERATE THE DIFFERENT SGA’S. TABULATE THE DIFFERENCES BETWEEN PROSEAL
LMA AND I-GEL AIRWAY(JUNE 2011).(2015)
 ROLE OF LMA IN DIFFICULT AIRWAY ALGORITHM(2013)

51 ) TM ANKYLOSIS

18
  A 20 YEAR OLD IS SCHEDULED FOR RELEASE OF TMJ ANKYLOSIS.DISCUSS THE PREOP
ASSESSMENT AND VARIOUS METHODS TO SECURE THE AIRWAY(DEC 2008). -DESCRIBE
BRIEFLY THE DIFFICULT AIRWAY ALGORITHM. HOW WILL YOU PERFORM AWAKE INTU-
BATION IN AN ADULT WITH RESTRICTED MOUTH OPENING?(DEC 2011,2003).[IJA 2011]
 MANAGEMENT OF UNANTICIPATED DIFFICULT AIRWAY IN A STEPWISE MANNER .(2013)
 PREDICTORS OF DIFFICULT MASK VENTILATION(2014)

 ATTENTUATION OF LARYNGOSCOPIC RESPONSE

 DISCUSS MEASURES TO ATTENUATE PRESSOR RESPONSE TO LARYNGOSCO-
PY/INTUBATION(JUNE 2011).

52) FOB

 DESCRIBE THE TECHNIQUES FOR ANAESTHETIZING THE AIRWAY FOR AWAKE FIBREOP-
TIC LARYNGOSCOPY AND INTUBATION THROUGH NASAL ROUTE IN AN ADULT WITH
RESTRICTED MOUTH OPENING(DEC 2010).
 .DESCRIBE THE ANATOMY OF LARYNX.HOW WOULD YOU ANAESTHETIZE THE AIRWAY
FOR AWAKE INTUBATION(JUNE 2009).

 AIRWAAY BLOCKS AND ANAESTHESIA. COMPLICATIONS A/W AIRWAY BLOCKS(2014)

 DESCRIBE STEPWISE RAPID SEQUENCE INTUBATION. INDICATIONS , DIFFEREENT MODI-
FICATIONS SUGGESTED, POSSIBLE PITFALLS(2014) (2017)

53) VOCAL CORD PALSIES

 N SUPPLY OF NOSE AND LARYNX (2013)

 DESCRIBE INNERVATIONS OF LARYNX. BRIEFLY DISCUSS VARIOUS PALSIES FOLLOWING
NERVE INJURY(JUNE 2011)(2015).[PG 13 –WYLIE 5TH ED]

54) SPINAL,EPIDURAL AND CAUDAL ANAESTHESIA.

 DESCRIBE THE BOUNDARIES OF EPIDURAL SPACE. DISCUSS COMPLICATIONS OF EX-

TRADURAL ANAESTHESIA 5 COMMON COMPLICATIONS(JUNE 2006)(JUNE 2007).[PG
153-RACE 2007, 2011]
 WHILE PERFORMING EPIDURAL PUNCTURE THERE WAS A DURAL PUNCTURE WHAT ARE
THE OPTIONS AVAILABLE TO THE ANAESTHETIST(2017)

19
  ANATOMY OF EPIDURAL SPACE AND METHODS OF IDENTIFICATION(DEC 2007)
 WHAT ARE THE DIFFERENCES BETWEEN A SUBDURAL AND SUBARACHNOID
BLOCK?WRITE THE CLINICAL FEATURES AND MANAGEMENT OF PDPH(DEC 2011)
.(2013) EPIDURAL BLOCK VS TOTAL SPINAL VS SUBDURAL BLOCK (2015)
 WHAT IS BARICITY. RELEVANCE OF IT IN SPINAL ANAESTHESIA(2014)
 ADJUVANTS USED IN INTRATHECAL BLOCK(2014)

RA IN CHILDREN.

55) CAUDAL EPIDURAL IN PAEDIATRICS

 DISCUSS INDICATIONS,TECHNIQUES AND COMPLICATIONS OF CAUDAL EPIDURAL

BLOCK IN CHILDREN(JUNE 2012,2009,2015).COMPLICATIONS OF CAUDAL BLOCK HOW
TO PREVENT (2014)

 ROLE OF REGIONAL ANAESTHESIA IN PAEDIATRIC SURGERY(JUNE 2002,2016).

 INDICATIONS,TECHNIQUES AND COMPLICATIONS OF SPINAL ANAESTHESIA IN PAEDI-
ATRIC PATIENTS UNDERGOING SURGERY(JUNE 2007,2006).[UPDATE IN ANAESTHESIA]

56) ANTICOAGULANTS AND RA

 ENUMERATE THE GUIDELINES, ANAESTEHTIC CONCERNS FOR RA IN A PATIENT ON

ANTIPLATELET THERAPY(JUNE 2009,2010 DEC 2011) (2015) .(2013)).

57) PDPH

 WHAT IS PDPH?WHAT ARE THE FACTORS AFFECTING IT?DESCRIBE THE MANAGEMENT

OF SUCH A CASE(DEC 2009).

NERVE BLOCKS.

58) STELLATE GANGLION BLOCK

 DESCRIBE THE ANATOMY OF STELLATE GANGLION .ENUMERATE THE INDICA-

TIONS,CONTRAINDICATIONS,COMPLICATIONS AND METHOD OF ESTABLISHING STEL-
LATE GANGLION BLOCK(DEC 2008)2010,2015.

59) BRACHIAL PLEXUS BLOCK

 DISCUSS ONE METHOD OF BRACHIAL PLEXUS BLOCK THROUGH SUPRACLAVICULAR

APPROACH AND ENUMERATE THE COMPLICATIONS ASSOCIATED WITH IT(JUNE
2007).[PG 333-MORGAN]

20
  ANATOMY OF BRACHIAL PLEXUS WITH THE HELP OF A DIAGRAM.ENUMERATE THE
VARIOUS TECHNIQUES OF BRACHIAL PLEXUS BLOCK(JUNE 2010) (2016)

60 ) COELIAC PLEXUS BLOCK

 DESCRIBE THE ANATOMY OF CELIAC PLEXUS WITH DIAGRAM.DISCUSS THE INDICATIONS AND
METHODS TO BLOCK CELIAC PLEXUS, COMPLICATIONS(JUNE 2009(DEC 2011,2014).[PG 385-
MORGAN 4TH ED]

61) ANKLE BLOCK

 DESCRIBE THE NERVE SUPPLY OF FOOT AND THE TECHNIQUE OF ANKLE BLOCK FOR AMPUTA-
TION OF GREAT TOE(DEC 2006). (2015)
 DESCRIBE THE REGIONAL BLOCK FOR REMOVAL OF INFECTED CORN FOOT(DEC 2010)
 36 YR OLD DM WITH POORLY CONTROLLED BLOOD SUGAR FOR REMOVAL OF INFECTED TOE
NAIL . WHICH TYPE OF REGIONAL ANAESTHESIA IS IDEAL AND WHY ,(2017)

62) PARAVERTEBRAL BLOCK

 DESCRIBE THE ANATOMY OF PARAVERTEBRAL SPACE WITH DIAGRAM.DESCRIBE ONE METHOD

OF ESTABLISHING PARAVERTEBRAL BLOCK(JUNE 2012,2007)

63) MISSCE BLOCK

 INTERPLEURAL BLOCK ADVANTAGHES AND DISADVANTAGES (2014)

 DESCRIBE WITH THE HELP OF A LABELED DIAGRAM,THE ANATOMY OF LUMBAR PLEX-

US AND DESCRIBE THE TECHNIQUES OF LUMBAR PLEXUS BLOCK(JUNE 2008).[PG 343-
MORGAN 4TH ED]
 DESCRIBE THE COURSE OF SCIATIC NERVE AND ANY ONE APPROACH TO BLOCK THE
NERVE(JUNE 2011).(2016)
 SCIATIC NERVE ROOT VALUE, BRANCHES ,. DESCRIBE LABARTS APPROACH OF SCIATIC
NERVE BLOCK.(2014).
 TAP BLOCK : TECHNIQUES AND INDICATIONS (2017)

IV FLUID AND ELECTROLYTE PHYSIOLOGY.

64) CRYSTALLOID/COLLOID

21
  DISCUSS THE DIFFERENT TYPES OF COLLOID SOLUTIONS.DESCRIBE THEIR AD-
VANTAGES AND DISADVANTAGES (JUNE2012)

 WHAT ARE THE DIFFERENT TYPES OF CRYSTALLOIDS USED IN SHOCK IN AN ADULT

PATIENT?MENTION THEIR COMPOSITION, ADVANTAGES & DISADVANTAGES.(2016)
 DISCUSS THE ROLE OF PLASMA PROTEINS IN ANAESTHESIA(JUNE 2007).FLUID COM-
PARTMENTS IN THE BODY , DESCRIBE HOW OEDEMA DEVELOPS (2014)
 BALANCED SALT SOLUTION (2016)
 ROLE OF ALBUMIN IN ICU AND CURRENT CONCEPTS OF IV FLUIDS IN ICU (2014)

 ROLE OF NOREPINEPHRINE AND VASOPRESSIN IN ICU (2014)

65) K+AND MG

 WHAT ARE THE PHYSIOLOGICAL FUNCTIONS OF MAGNESIUM?DESCRIBE ITS THERA-

PEUTIC USES IN ANAESTHESIA(JUNE 2012)(2004,2006,2007

 HYPOKALEMIA-DEFINITION,CLINICAL MANIFESTATION AND MANAGEMENT(JUNE

2010,2011).
 DEFINE HYPERKALEMIA.DISCUSS SIGNS AND SYMPTOMS AND ANAESTHETIC CONSID-
ERATION(JUNE 2009,2011,2106).[PG 680-MORGAN]
 DISCUSS THE ECG ABNORMALITIES DUE TO VARIOUS ELECTROLYTE IMBALANCES(DEC
2008).[PG 679-MORGAN 4TH ED]

66 ) SIADH

 WHAT IS SIADH?DESCRIBE THE CLINICAL FEATURES AND MANAGEMENT OF SIADH(DEC

2011)
 DESCRIBE THE CAUSES AND MANAGEMENT OF ACUTE DILUTIONAL HYPONATREMIA IN
THE IMMEDIATE POSTOPERATIVE PERIOD(DEC 2012) (2013)

67) NA+

 ENUMERATE THE SIGNS AND SYMPTOMS OF HYPONATREMIA.DESCRIBE THE MANAGE-

MENT IN A PATIENT WITH SERUM SODIUM LEVEL OF 115 MEQ/L SCHEDULED FOR KNEE
REPLACEMENT UNDER RA(DEC 2009). [PG 671-MORGAN] (2016)
 SIGNS AND SYMPTOMS OF HYPONATREMIA WITH RESPECT TO SERUM SODIUM LEV-
ELS.(2017)

68 ) CA2+

22
  DISCUSS CAUSES,CLINICAL MANIFESTATIONS AND TREATMENT OF HYPERCALCEMIA..WHAT ARE
THE ANAESTHETIC CONSIDERATIONS?(JUNE 2012)

ANAESTHESIA FOR CARDIAC SURGERY

69 ) CARDIAC PHYSIOLOGY

 DESCRIBE CORONARY CIRCULATION.DISCUSS FACTORS AFFECTING OXYGEN DEMAND

AND SUPPLY TO THE MYOCARDIUM(DEC 2010).

70 ) ARRYTHMIAS

 DESRIBE THE CARDIAC CONDUCTION SYSTEM. HOW DO YOU MANAGE A PATIENT

WITH PSVT?(DEC 2010) DEC 2009). (2015).
 DESCRIBE THE COMMON ARRHYTHMIAS ENCOUNTERED DURING PRE-OPERATIVE PERI-
OD.DISCUSS THE THERAPEUTIC USES OF AMIODARONE(JUNE 2011). IN THE IN-
TRAOPERATIVE PERIOD , CAUSES AND MGT (2013)
 DISCUSS THE ETIOLOGY AND MANAGEMENT OF SUPRA VENTRICULAR ARRHYTHMIAS
DURING SURGERY UNDER GA(JUNE 2012)

71) PMI

 DISCUSS THE DIAGNOSIS AND MANAGEMENT OF MI IN A PATIENT UNDERGOING NON-

CARDIAC SURGERY(DEC 2008)[PG 287-302-IJA 2007]

 DISCUSS THE PREOPERATIVE EVALUATION AND ANAESTHETIC MANAGEMENT OF A 45

YEAR OLD MALE WITH HISTORY OF MI 3 MONTHS BACK AND IS SCHEDULED TO UN-
DERGO EXPLORATORY LAPAROTOMY(JUNE 2011).

72) CPB

 MYOCARDIAL PRESERVATION(JUNE 1994)(JUNE 2004)(2014)

 ANTICOAGULATION AND CPB(DEC 2007).[PG 1088-BARASCH]
 CARDIOPLEGIA AND ITS ROLE IN CARDIAC ANAESTHESIA PRACTICE(DEC 2007).[PG
439-SATISH DESHPANDE] CARDIOPLEGIA AND ROLE IN MYOCARDIAL PRESERVA-
TION(2014)

23
  DISCUSS THE VARIOUS CRITERIA REQUIRED BEFORE WEANING A PATIENT FROM
CPB(JUNE 2011).
 DESCRIBE THE COMMONLY ENCOUNTERED PROBLEMS FOLLOWING CPB IN THE POST-
BYPASS PERIOD(DEC 2012).
 DESCRIBE THE PATHOPHYSIOLOGY OF AORTIC CROSS CLAMPING. BRIEFLY DESCRIBE
RENAL PROTECTION DURING CROSS CLAMPING. .(2013)

 HAEMODYNAMIC AND METABOLIC CHANGES FOLLOWING AORTIC CROSS CLAMPING.

THERAPEUTIC INTERVENTIONS FOR MANAGING THESE CHANGES.(2015)
 DIFF B/W PARTIAL AND TOTAL CARDIOPULMONARY BYPASS (2014)
 3.DISCUSS HEMODYNAMIC AND METABOLIC CHANGES DURING AORTIC CLAMPING
AND CROSS CLAMPING.DESCRIBE THE RENAL PROTECTIVE MEASURES DURING AORTIC
CLAMPING(JUNE 2011).

73) OPCAB

 ENUMERATE THE INDICATIONS OF OPCAB.DESCRIBE THE TECHNIQUE,ADVANTAGES

AND DISADVANTAGES(DEC 2009,2006).[PG 177-RACE 2009]

 DISCUSS ANAESTHETIC MANAGEMENT OF 20 YEARS OLD MALE WITH RHD WITH MS

FOR CLOSED MITRAL VALVOTOMY(JUNE 2007).
 PREOP EVALUATION AND ANAESTHEITC MANAGEMENT OF A 30 YEAR OLD PATIENT
WITH MS AND AF SCHEDULED FOR BALLOON ANGIOPLASTY AND VALVOPLASTY(DEC
2007).
 ENUMERATE THE CIRCULATORY ASSIST DEVICE.WHAT ARE THE INDICA-
TIONS,CONTRAINDICATIONS AND COMPLICATIONS OF IABP?(DEC 2010,2012).

74) CARDIAC TRANSPLANT

 PREOP ANAESTHETIC IMPLICATIONS IN A PATIENT WITH TRANSPLANTED HEART

POSTED FOR INCIDENTAL SURGERY(DEC 2007).[PG 22-STOELTING]
 ANAESTHESIA FOR CORRECTION OF CARDIAC ARRYTHMIAS(PACEMAKERS)
 SPECIFIC PROBLEMS AND THEIR PREVENTION DURING ANAESTHESIA IN A PATIENT
WITH ARTIFICIAL PACEMAKER(DEC 2000,2002,2007).[RACE 2008,PG 437-RACE 2009]
 ENUMERATE THE EVIDENCED BASED INDICATIONS FOR PACEMAKER INSER-
TION.MENTION THE GENERAL PRINCIPLES OF ANAESTHETIC MANAGEMENT OF A PA-
TIENT WITH PACEMAKER SCHEDULED FOR SURGERY(DEC 2009). (2015)

24
  WHAT ARE THE INDICATIONS FOR ELECTIVE CARDIOVERSION? HOW DO YOU PREPARE
AND PERFORM THIS PROCEDURE?(DEC 2006). (DEC 2007).
 MANAGEMENT OF A PT WITH PULSELESS VT/VF IN A HOSPITAL (2016)

75 ) CORONARY STENT

 EVALUATION OF CARDIAC PATIENT FOR NON –CARDIAC SURGERY(JUNE 2004).(2015)

 ENUMERATE THE RCRI. DRAW THE ALGORITHM OF CARDIAC EVALUATION FOR NON-
CARDIAC SURGERY AS RECOMMENDED IN ACC/AHA 2007 GUIDELINES ON PERI-
OPERATIVE CVS EVALUATION AND CARE(JUNE 2010).
 WHAT ARE THE PREDICTORS OF CARDIAC RISK IN CARDIAC PATIENTS UNDERGOING
NON CARDIAC SURGERY?DESCRIBE BRIEFLY THE ANAESTHETIC CONSIDERATION IN A
PATIENT WITH CORONARY ARTERY DISEASE WITH EJECTION FRACTION OF 40% FOR
LAPAROSCOPIC CHOLECYSTECTOMY(DEC 2012).
 HOW WILL YOU EVALUATE A 50 YEAR OLD MALE PATIENT WITH HISTORY OF IHD PRE-
SENTING FOR MAJOR ABDOMINAL SURGERY?(DEC 2011).
 DRAW THE ALGORITHM FOR PREOPERATIVE MANAGEMENT OF A PATIENT RECEIVING
ANTIPLAELET THERAPY AS RECOMMENDED BY ACC/AHA GUIDELINES IN PERIOPERA-
TIVE CARDIOVASCULAR EVALUATION AND CARE.DESCRIBE THE PREOPERATIVE MAN-
AGEMENT OF A PATIENT WITH CORONARY STENT(DEC 2009,2008,2010,2014)[PG 235-
ISACON 2009]

76) CARDIAC PATIENT FOR NON CARDIAC SURGERY

 CLASSIFY CARDIOMYOPATHIES. DESCRIBE MANAGEMENT OF A 60 YEAR OLD MALE

WITH DILATED CARDIOMYOPATHY SCHEDULED FOR LAPAROTOMY(DEC 2010) DE-
SCRIBE MGT OF HYPERTROPHIC CARDIOMYOPATHY PT POSTED FOR TAH (2013)
 WHAT IS DIASTOLIC DYSFUNCTION?DISCUSS THE EVALUATION AND IMPLICATIONS TO
THE ANAESTHETISTS(DEC 2011(2017)).[CHAPTER 6-STOELTING CO-EXISTING]

77) VHD

 DISCUSS THE ANAESTHETIC MANAGEMENT OF 20 YEAR OLD MALE WITH RHD WITH MS
FOR CLOSED MITRAL VALVOTOMY(JUNE 2007).[PG 3 –OAR,PG 31-STOELTING]

78) ANESTHESIA FOR PAEDIATRIC CARDIAC SURGERY.

25
  HOW WILL YOU EVALUATE A THREE YEAR OLD CHILD WITH SYSTOLIC MURMUR
SCHEDULED FOR SURGERY?BRIEFLY DISCUSS THE ANAESTHETIC IMPLICATIONS?(DEC
2012).

 WRITE PRINCIPLES AND ANAESTHETIC MANAGEMENT OF A 3 YEAR OLD CHILD

SCHEDULED FOR PDA LIGATION(JUNE 2008).[PG 795-OHA][PG 47-STOELTING] (2015).
 CAUSES AND MANIFESTATIONS OF CONGENITAL CYANOTIC HEART DISEASE, BRIEFLY
DISCUSS THE ANAESTHETIC MGT IN A CASE OF TOF (2013)

79) ANAESTHESIA FOR VASCULAR SURGERY.

 ROLE OF ANAESTHETIST IN A CASE OF TAO(JUNE 2002).

 DESCRIBE THE ANAESTHETIC MANAGEMENT IN A PATIENT WITH ABDOMINAL AORTIC
DISSECTION SCHEDULED FOR AORTIC BYPASS GRAFT(DEC 2009).[PG 226-RACE 2010]
 DESCRIBE THE PREOPERATIVE EVALUATION,ANAESTHETIC MANAGEMENT AND INTRA
OPERATIVE MONITORING OF A PATIENT SCHEDULED FOR ENDARTERECTOMY(DEC
2012).

80 ) ANAESTHESIA FOR BARIATRIC SURGERY.

 DEFINE BMI.CLASSIFY OBESITY AND DISCUSS THE ANAESTHETIC CONSIDERATIONS IN

A MORBIDLY OBESE PATIENTS(DEC 2011,2006,2007,2008).[PG 289-OAR]
 DEFINE MORBID OBESITY.ENUMERATE THE CHANGES THAT OCCUR IN THE RESPIRA-
TORY,CARDIOVASCULAR AND METABOLIC SYSTEMS IN OBESITY.A 40 YEAR OLD PA-
TIENT WITH HEIGHT 158 CMS AND WEIGHING 150 KS IS SCHEDULED FOR PYELOLI-
THOTOMY.HOW WILL YOU EVALUATE THIS PATIENT PREOPERATIVELY?DISCUSS THE
PROBLEMS INVOLVED AND THE ANAESTHETIC MANAGEMENT(JUNE 2000).
 DISCUSS THE PROBLEMS AND THEIR ANAESTHETIC IMPLICATIONS OF A 40 YEAR OLD
MORBIDLY OBESE PATIENT SCHEDULED FOR GASTRIC BANDING(JUNE 2009) (JUNE
2010). .(2013). 14.DESCRIBE BRIEFLY THE INTRA OPERATIVE CONSIDERATIONS FOR
BARIARTRIC SURGERY.(DEC 2012)
 DISCUSS THE PREOPERATIVE EVALUATION OF A 25 YEAR OLD MAN WITH OSA
ACHEDULED FOR LAPAROTOMY.HOW WOULD YOU PREPARE HIM FOR SURGERY(JUNE
2012)[PG 79-RACE 2012].
 TUMESCENT TECHNIQUE FOR LOCAL ANAESTHESIA IN A PATIENT UNDERGOING LIPO-
SUCTION AND ABDOMINOPLASTY.

81) ANAESTHESIA FOR LAPAROSCOPIC SURGERY.

26
  DISCUSS THE PHYSIOLOGICAL CHANGES DUE TO PNEUMOPERITONEUM IN LAPARO-
SCOPIC ABDOMINAL SURGERY.LIST THE INTRA-OPERATIVE COMPLICATIONS(JUNE
2011,2009).

ANAESTHESIA FOR OBG

PIH

82) HELLP SYNDROME

 HELLP SYNDROME:ROLE OF ANAESTHESIOLOGIST(JUNE 2007JUNE 2010)

 MG SO4 THERAPY(DEC 2000).[PG 387-RACE 2011,PG 142-OAR]
 A 35 WEEKS PREGNANT PT WITH BP OF 200/100 MMHG,EDEMA AND ALBUMINURIA IS
TO BE PREPARED FOR ELECTIVE CS.DISCUSS PREPARATION AND PREFERRED ANAES-
THESIA TECHNIQUE(REGIONAL OR GENERAL)(DEC 2003)
 ANAESTHETIC MANAGEMENT OF PATIENT WITH SEVERE PRE ECLAMPSIA FOR CS(JUNE
2008).
 DISCUSS THE PERIOPERATIVE EVALUATION AND MANAGEMENT OF A 30 YEAR OLD
PRIMI ADMITTED AT 36 WEEKS OF PREGNANCY WITH ECLAMPSIA PRESENTING FOR
EMERGENCY LSCS(JUNE 2009).(2015).
 DESCRIBE THE ANAESTHETIC MANAGEMENT OF A PATIENT WITH PIH SCHEDULED FOR
CS(DEC 2009).PIH VS ESSENTIAL HTN .(2013) (JUNE 2007). [PG 128-OAR}
 DISCUSS THE ANAESTHETIC MANAGEMENT OF A FULL TERM PRINIGRAVIDA WITH SE-
VERE PRE ECLAMPSIA,SCHEDULED FOR EMERGENCY CS(JUNE 2011).[PG 375-RACE 2011]

83) NON OBSTETRIC SURGERY DURING PREGNANCY

 ANAESTHESIA FOR A PREGNANT WOMAN FOR NON-OBSTETRIC SURGERY(DEC 2005).

 LAPAROSCOPIC SURGERY IN A PREGNANT PATIENT(JUNE 2006).
 OUTLINE THE ANAESTHETIC MANAGEMENT OF A FEMALE WITH 28 WEEKS PREGNANCY
SCHEDULED FOR EMERGENCY APPENDICECTOMY(JUNE 2010) (2017) [RACE
2003,ISACON 2007]

 DESCRIBE THE PHYSIOLOGICAL CHANGES OF CARDIOVASCULAR AND RESPIRATORY

SYSTEMS IN PREGNANCY.DISCUSS THE ANAESTHETIC CONSIDERATIONS AND MAN-
AGEMENT OF PREGNANT PATIENT UNDERGOING NON-OBSTETRIC SURGERY DURING
FIRST TRIMESTER(DEC 2011) (2016) (DEC 2008).[PG 63-ARC 5,PG 875-MORGAN 4TH ED]

27
  WHAT IS MENDELSON’S SYNDROME?ENUMERATE ACID ASPIRATION PROPHYLAXIS IN A
PATIENT SCHEDULED FOR EMERGENCY CS(JUNE 2010).
 TECHNIQUES TO PREVENT HYPOTENSION AFTER SA IN CS(DEC 2007).
 WHAT ARE THE OBJECTIVES OF PREMEDICATION IN A PATIENT SCHEDULED FOR ELEC-
TIVE CS?DESCRIBE THE DRUGS USED WITH THEIR DOSES AND RATIONALE(JUNE 2012)
 PROBLEMS AND MANAGEMENT OF PREGNANT PATIENT WITH DILATED CARDIOMYO-
PATHY ON TREATMENT FOR EMERGENCY LSCS(JUNE 2005).
 PRE-ANAESTHETIC EVALUATION OF A PATIENT OF MS FOR MTP AND STERILIZA-
TION(DEC 2005).
 ENUMERATE THE PERIOPERATIVE PROBLEMS AND ANAESTHETIC MANAGEMENT OF A
28 YEAR OLD PATIENT WITH MS FOR ELECTIVE CS(DEC 2008).
 DISCUSS THE PRE OPERATIVE EVALUATION AND MANAGEMENT OF A 30 YEAR OLD
FEMALE PATIENT WHO UNDERWENT MITRAL VALVE REPLACEMENT 6 MONTHS AGO
AND IS NOW SCHEDULED FOR MTP WITH LAPAROSCOPIC STERILISATION(DEC 2006).
 PREOP PREPARATION , PREMEDICATION AND ANAESTHEIC GOALS IN A PT WITH MI-
TRAL VALVE AREA OF 1 SQ CM. POSTOP MGT . (2015) [IJA 2010-ISSUE 5 –REVIEW ARTI-
CLE]
 A HIV POSITIVE PATIENT IS SCHEDULED FOR ELECTIVE CS. DESCRIBE THE PRECAU-
TIONS FOR THE MANAGEMENT OF THIS PATIENT(DEC 2009).

 WHAT ARE UNIVERSAL PRECAUTIONS FOR HIV, HBV & HCV? TRANSMISSION BASED
PRECAUTIONS.(2016)

84) LABOUR ANALGESIA

 DISCUSS THE PHYSIOLOGICAL CHANGES SECONDARY TO PAIN IN LABOUR.DESCRIBE

THE ROLE OF PARA-CERVICAL AND PUDENDAL NERVE BLOCKS IN OBSTETRIC ANALGE-
SIA(DEC 2011).
 DRAW A LABELED DIAGRAM OF LABOR PAIN PATHWAY.DESCRIBE METH-
OD,ADVANTAGES AND DISADVANTAGES OF PREFERRED TECHNIQUE OF LABOR ANAL-
GESIA(2006).DEC 2012)

85) MISCE OBG

 AMNIOTIC FLUID EMBOLISM(DEC 1994).

 ROLE OF ANAESTHESIOLOGIST IN AN OBSTETRIC UNIT(DEC 2005).

28
  REGIONAL VS GA IN OBSTETRIC SURGERY(DEC 2005).
 MEDICAL ASPECT AND OBSTETRICS(DEC 2003).
 WHAT ARE THE CAUSES OF OBSTETRIC HAEMORRHAGE ? DESCRIBE ITS MANAGEMENT
INCLUDING ANAESTHESIA (DEC 2010).(2016)
 STEPWISE MGT OF UTERINE ATONY DURING LSCS (2016)
 USE OF TRANEXAMIC ACID AND ACTIVATED FACTOR 7 IN THE MANAGEMENT OF OB-
STETRIC HEMORRHAGE(2014)
 APGAR SCORE (2016)

ANAESTHESIA FOR ORTHOPAEDICS.

86) THR , TKR

 A 60 YEAR OLD WOMEN WITH RA IS FOR THR. DISCUSS THE ANAESTHETIC PROBLEMS
AND MANAGEMENT(JUNE 1994)
 AN 80 YEAR OLD MALE IS POSTED FOR TOTAL HIP REPLACEMENT. DISCUSS THE PRE-
OPERATIVE EVALUATION,PREPARATION AND ANAESTHETIC MANAGEMENT OF THIS
CASE(JUNE 2002,2005,2008,2010).[PG 205-ISACON 2009] MENTION THE METHODS OF
POSTOP PAIN RELIEF(DEC 2009).
 WHAT ARE THE CAUSES OF INTRA OPERATIVE HYPOTENSION DURING TOTAL HIP RE-
PLACEMENT?OUTLINE THE TREATMENT STRATEGIES(DEC 2012)
 ANAESTHETIC CONSIDERATION OF A PATIENT FOR SURGERY FOR FRACTURE NECK OF
FEMUR, ONE YEAR AFTER CABG(DEC 2005).
 AN 86 YEAR OLD PATIENT IS SCHEDULED FOR OPEN REDUCTION AND INTERNAL FIXA-
TION OF SUBTRONCHANTERIC FRACTURE OF FEMUR.DISCUSS THE PREOPERATIVE
EVALUATION AND ANAESTHETIC MANAGEMENT OF THIS PATIENT(DEC 2006).
 ANAESTHESIA IN A 75 YR OLD PT POSTED FOR TKR (2015) .(2013)

 WHAT ARE THE INDICATIONS AND CONTRAINDICATIONS FOR USE OF ARTERIAL

TOURNIQUET.WHAT COMPLICATION MAY ARISE FROM THE USE OF SUCH TOURNI-
QUET(JUNE 2005).
 PROBLEMS ENCOUNTERED BY ANAESTHETISTS DURING THE ORTHOPAEDIC OPERATIVE
PROCEDURES(JUNE 2005).

87) SCOLIOSIS

 DISCUSS THE ANAESTHETIC PROBLEMS,PREOPERATIVE PREPARATION AND ANAES-

THETIC MANAGEMENT OF A CASE POSTED FOR CORRECTION OF KYPHOSCOLIO-
SIS(JUNE 1995).

29
  ENUMERATE THE ANTICIPATED PROBLEMS IN AN ADULT PATIENT WITH: SCOLIOSIS AT
THORACIC LEVEL. (2016)2006
88) VAE , FAT EMBOLISM

 DESCRIBE PATHOPHYSIOLOGY,CLINICAL FEATURES,DIAGNOSIS AND MANAGEMENT OF

FAT EMBOLISM(DEC 2010,2002). 2.POST TRAUMATIC FAT EMBOLISM(JUNE 2001)(DEC
2001).
 DISCUSS THE CAUSES, PATHOPHYSIOLOGY.SIGNS AND SYMPTOMS AND MANAGEMENT
OF VAE(JUNE 2009) . (DEC 2010).2011
 RISK FACTORS FOR VENOUS THROMBOEMBOLISM AND CLASSIFY THE CURRENT
METHODS OF PREVENTION WITH EXAMPLES(DEC 2005) DIAGNOSIS AND MANAGEMENT
OF VENOUS AIR EMBOLISM (2015) .(2013)
 HOW DO YOU DIAGNOSE DVT? DESCRIBE THE PREDISPOSING FACTORS AND ITS MAN-
AGEMENT, PROPHYLACTIC STRATEGIES (2013,2009,2008)

ANAESTHESIA FOR TRAUMA.

89) ANESTHESIA FOR PREHOSPITAL EMERGENCY AND TRAUMA CARE.

 GOLDEN HOUR(JUNE 2002).

 WHAT DO YOU MEAN BY THE GOLDEN HOUR IN TRAUMA?DISCUSS THE ROLE OF
ANAESTHETIST IN RESUSCITATION OF TRAUMA PATIENT(JUNE 2006 JUNE 2007).[PG
538-ISACON 2011,PG 287-RACE 2012]

 WHAT IS TRIAGE?WHAT ARE TRIAGE CRITERIA IN RELATION TO TRAUMA?(DEC 2008).

 IMPORTANCE OF TRIAGE IN MASS CASUALTY INCIDENT(JUNE 2010).[PG 2327-2328-
MILLER]
 WHAT DO YOU MEAN BY MULTI-CASULATY TRIAGING?WHY IS IT IMPORTANT?HOW DO
YOU TRIAGE VICTIMS IN THE CASUALTY FOLLOWING A MASS DISASTER?(JUNE 2011).
 ANAESTHESIA AND RESUSCITATIVE SERVICES FOR DISASTER MGT(2013)

 PRE-HOSPITAL TRAUMA CARE(DEC 2001).

 ROLE OF ANAESTHETIST IN MULTIPLE TRAUMA(DEC 2001).[PG 113-ISACON 2007]
 HOW WILL YOU DO ANAESTHETIC MANAGEMENT IN 10 YEARS OLD CHILD WITH MUL-
TIPLE INJURIES?(JUNE 2003).
 ASSESSMENT OF AN ADULT WHO SUSTAINED MULTIPLE TRAUMA OF FEW HOURS DU-
RATION(DEC 2004).
 WHAT ARE THE FACTORS THAT PREDISPOSE TRAUMA PATIENTS TO INCREASED AN-
AESTHETIC RISKS?BRIEFLY MENTION THEIR MANAGEMENT(DEC 2012)

30
  PRIORITIES IN TRAUMA CARE (2016)

90) ANAESTHESIA FOR GERIATRICS.

 AGEING AND ORGAN FUNCTION(JUNE 2001)(DEC 2001).(2014)

 ENUMERATE AGE RELATED CHANGES IN CVS,RS,NS AND RENAL SYSTEMS IN GERIAR-
TRIC PATIENT WHICH CAN AFFECT ANAESTHETIC MANAGEMENT. HOW DO THE
CHANGES IN RENAL FUNCTIONS AFFECT ANAESTHETIC MANAGEMENT?(DEC 2012)

91) CHEMICAL AND BIOLOGICAL WARFARE AGENTS:THE ROLE OF THE ANAESTHESIOLO-

GIST.

 ENUMERATE THE CLASSICAL BIOLOGICAL WARFARE AGENTS.DESCRIBE PHYSICAL FIND-

INGS,PATHOGENESIS AND TREATMENT OF ANTHRAX(DEC 2010).

92) ANAESTHESIA FOR EYE.

 A 4 YEAR OLD CHILD IS SCHEDULED FOR EMERGENCY REPAIR OF PENETRATING EYE

INJURY OF THE EYE.DISCUSS THE ANAESTHETIC MANAGEMENT(DEC 2006,2009,2012).
 ANAESTHESIA FOR SQUINT SURGERY(1996-2000). (2015)
 OCCULOCARDIAC REFLEX(JUNE 1995)(JUNE 2001)(DEC 2001)(DEC 2006). (2015)
 ANAESTHESIA FOR INTRAOCULAR SURGERY(JUNE 2001)(DEC 2001).
 PERIBULBAR BLOCK, RETROBULBAR BLOCK -INDICATIONS, TECHNIQUES AND COMPLI-
CATIONS(JUNE 2010)(2014,2002(2006, 2015).
 ENUMERATE CAUSES OF POSTOPERATIVE VISUAL LOSS.DESCRIBE THE PATHOPHYSIOL-
OGY AND ITS MANAGEMENT(DEC 2010).

93) ANESTHESIA FOR ENT AND LASER SURGERY.

 ANAESTHETIC CONSIDERATIONS AND MANAGEMENT OF A CHILD WITH POST-

TONSILLECTOMY BLEEDING(JUNE 2002)(JUNE 2005)(JUNE 2006)2012.DEC 2007).[PG
174-RACE 2011]
 ANAESTHESIA AND PAIN MGT IN A CASE OF 10 YR OLD FOR ADENOTONSILECTOMY.
 ANAESTHETIC MANAGEMENT OF A CHILD WITH RETROPHARYNGEAL ABSCESS PRE-
SENTING FOR SURGICAL DRAINAGE(JUNE 1995).
 PROBLEMS OF MICROLARYNGEAL SURGERY(DEC 1995). DESCRIBE THE OPTIONS AVAIL-
ABLE FOR MAINTAINING THE AIRWAY IN MICROLAYNGEAL SX, ANAESTHETIC CON-
CERNS, POST OP PROBLEMS, THEIR PREVENTION AND MGT (2014) (2013)

31
  DISCUSS THE ANAESTHETIC MANAGEMENT OF A 70 YEAR MAN WITH CARCINOMA
LARYNX FOR TOTAL LARYNGECTOMY(JUNE 2007,1998)
 ANAESTHETIC MANAGEMENT OF A 22 YEAR OLD MALE PATIENT WITH MULTIPLE PAP-
ILLOMAS OF LARYNX WHO IS SCHEDULED FOR LASER EXCISION.

 ANAESTHETIC PROBLEMS IN LASER SURGERY(JUNE 2002)(DEC 2004),1996,1997,1999.

 A 22 YEAR OLD MALE PATIENT WITH MULTIPLE PAPILLOMA OF LARYNX IS SCHEDULED
FOR LASER EXCISION.DESCRIBE THE ANAESTHETIC MANAGEMENT(DEC 2009).BRIEFLY
DESCRIBE PREVENTIVE MEASURES (2016) (2015)
 PREOP ASSESSMENT, PREPARATION AND ANAESTHETIC MGT OF 14 YR OLD CHILD FOR
NASAL ANGIOFIBROMA (2017)
 WRITE THE BLOOD CONSERVATION STRATEGIES IN A 20 YEAR OLD FEMALE SCHED-
ULED FOR EXCISION OF ANGIOFIBROMA OF NOSE(JUNE 2008).[PG 65-RACE 2009]

94) ANAESTHESIA FOR ROBOTIC SURGERY.

 DISCUSS THE ANAESTHETIC PROBLEMS IN ROBOTIC SURGERY(JUNE 2012) (2014)(2007)

95) ECT

 ANAESTHETIC CONSIDERATIONS FOR MODIFIED ECT(DEC 2007).

 A 60 YEAR OLD MALE WITH REFRACTORY DEPRESSION IS SCHEDULED FOR
ECT.DESCRIBE THE ANAESTHETIC MANAGEMENT(DEC 2009).

96) CLINICAL CARE IN EXTREME ENVIRONMENTS AT HIGH AND LOW PRESSURE IN SPACE.

97) WHAT ARE THE PROBLEMS WITH ACUTE EXPOSURE TO HIGH ALTITUDE?DISCUSS
BRIEFLY THE ANAESTHETIC CONSIDERATIONS AT HIGH ALTITUDE(JUNE 2011).
(2016)(2017)

98) PAEDIATRIC ANAESTHESIA

 HOW DOES THE PAEDIATRIC AIRWAY DIFFER FROM THAT OF AN ADULT?WHAT ARE
THE IMPLICATIONS FOR AN ANAESTHESIOLOGIST(DEC 2009).[PG 36-IJA 2004,PG923-
MORGAN]

32
  WHAT ARE THE METHODS OF PAIN ASSESSMENT IN INFANTS AND CHILDREN AND
NON COMMUNICATING ADULT ?DISCUSS THE PHARMACOLOGICAL MANAGEMENT OF
ACUTE PAIN IN PAEDIATRIC PATIENTS(DEC 2011).[PG 1267 WILEY 7 TH ED,PG 203-RACE
2012],IJA 2004

99) TEF

 PRE-ANAESTHETIC ASSESSMENT AND PREPARATION OF ONE DAY OLD NEONATE FOR

TEF REPAIR(JUNE 2007,2009,2011).[PG 941-MORGAN]

100) FOREIGN BODY

 A 2YEAR OLD CHILD IS SCHEDULED FOR REMOVAL OF ORGANIC BODY IN THE RIGHT BRON-
CHUS.WHAT IS THE ANAESTHETIC MANAGEMENT?(DEC 2008). [IJA 2007] (2015) (DEC 2007).[PG
186-REBECCA JACOB](2011)

 INDICATIONS OF MEDIASTINOSCOPY. ANAESTHETIC IMPLICATIONS IN A PATIENT SCHEDULED

FOR MEDIASTINOSCOPY.(2015)

101) CDH

 PERIOPERATIVE PROBLEMS AND ANAESTHETIC MANAGEMENT OF A ONE DAY OLD CHILD WITH
DIAPHRAGMATIC HERNIA(DEC 2008,2009,2010,2014).
 DESCRIBE THE PATHOPHYSIOLOGY,CLINICAL MANIFESTATIONS AND ANAESTHETIC MANAGE-
MENT OF CDH IN A NEONATE(DEC 2011)[PG 111-RACE 2012]
 ANAESTHETIC RISKS IN A PREMATURE NEONATE,DISCUSS THE PROGNOSTIC INDICATORS IN A
CDH NEONATE POSTED FOR SX (2014)

102) GENERAL

 FASTING GUIDELINES FOR CHILDREN.HOW DOES PREMEDICATION IN ADULTS DIFFER

FROM THAT IN CHILDREN(DEC 2007)[PG 400-401-RACE 2010]
 DISCUSS THE ANAESTHETIC IMPLICATIONS AND PERIOPERATIVE MANAGEMENT OF A
SIX MONTH OLD CHILD SCHEDULED FOR EXCISION OF CYSTIC HYGROMA(DEC
2011).[IJA VOL 55,ISSUE 6,NOV-DEC 2011]
 ENUMERATE THE MAJOR CONCERNS FOR ANAESTHESIOLOGIST IN HYPERTROPHIC PY-
LORIC STENOSIS IN A NEWBORN.WRITE DOWN THE ANAESTHETIC MANAGEMENT OF
SUCH A CASE(DEC 2012).

33
103) FETAL ANAESTHESIA.

 ANAESTHETIC IMPLICATIONS OF FETAL SURGERY(DEC 2007).[IJA 2009,PG 432-ISACON

2011,CEACCP 2008]
 DRAW A LABELED DIAGRAM TO ILLUSTRATE THE FETAL CIRCULATION.WHAT ARE THE CIRCU-
LATORY CHANGES THAT OCCUR AT BIRTH?(DEC 2008)(2014).[PG 884-MORGAN]

ACUTE POSTOPERATIVE PAIN.

104) PRE EMPTIVE ANALGESIA

 RECENT VIEWS ON PRE-EMPTIVE ANALGESIA(JUNE 2007).DRUGS USED , THEIR AD-

VANTAGES AND SIDE EFFECTS (2015)(2008)(2010)
 ACUTE PAIN MANAGEMENT SERVICE(JUNE 2006).
 OUTLINE THE VARIOUS MODALITIES FOR MANAGEMENT OF POSTOPERATIVE PAIN
FOLLOWING MAJOR ABDOMINAL SURGERY.ENUMERATE THE DIFFERENCES BETWEEN
ACUTE AND CHRONIC PAIN(JUNE 2010).

105) ANAESTHESIA FOR TREATMENT OF CHRONIC PAIN.

 WHO REGIMEN OF CHRONIC PAIN MANAGEMENT(JUNE 1997).[PG 26-RACE 2005]

 THE WHO THREE STEP LADDER PATTERN FOR PAIN RELIEF IN ADVANCED CANCER(DEC
1997)(DEC 2001).

 WHAT IS THE INTERNATIONAL ASSOCIATION FOR STUDY OF PAIN (IASP) DEFINITION OF

PAIN? B) CLASSIFY PAIN. C) INTERDISCIPLINARY MANAGEMENT OF PAIN.(2017)
 CHRONIC PAIN DRUGS USED AND SITE OF ACTION , MOA , COMPLICATION OF EACH
DRUG (2015)

 ROLE OF ANAESTHESIOLOGIST IN MANAGING SHOULDER DYSTROPHY SYNDROME(DEC

1994).
 TRIGEMINAL NEURALGIA,CLINICAL FEATURES AND MANAGEMENT(DEC 1996).[PG 375
AND 408-MORGAN]
 MANAGEMENT OF REFLEX SYMPATHETIC DYSTROPHY(JUNE 1997).[PG 406-MORGAN]
 PHANTOM LIMB PAIN(JUNE 2006).
 PAIN MANAGEMENT OPTIONS IN A PATIENT WITH INTRACTABLE PAIN DUE TO CARCI-
NOMA OF HEAD OF PANCREAS(DEC 2007)(JUNE 2011).[PG 297-RACE 2010] (2014)

34
  EXPLAIN THE TERM CRPS? WHAT ARE THE TYPES OF CRPS?DESCRIBE ITS CLINICAL
FEATURES AND OPTIONS FOR TREATMENT(JUNE 2012)2009, 2015.
 WHAT IS IASP(INTERNATIONAL ASSOCIATION FOR STUDY OF PAIN) DEFINITION OF
PAIN?HOW DO YOU CLASSIFY PAIN?BRIEFLY DESCRIBE THE INTERDISCIPLINARY MAN-
AGEMENT OF CHRONIC PAIN.(DEC 2012).
 WHAT IS HOSPICE?WHEN SHOULD YOU BEGING HOSPICE CARE? WHO PROVIDES IT ,
HOW DOES HOSPICE SERVE PATIENTS AND FAMILIES?(DEC 2012)
 PAIN MGT STRATEGIES FOR HOSPICE CARE (2015)
 WHAT ARE THE ACUTE AND LONGTERM AFFECTS OF POSTIOPERATIVE PAIN . DESCRIBE
CHRONIC POST SURGICAL PAIN (CPSP) AND METHODS TO PREVENT IT .(2013)

SECTION CRITICAL CARE MEDICINE

POISONING

106) OP POISONING

 DESCRIBE THE IN-HOSPITAL MANAGEMENT OF OP POISONING(JUNE 2009).

 WHAT ARE THE SIGNS AND SYMPTOMS OF OP POISONING?DISCUSS IT’S MANAGE-

MENT(JUNE 2011).;AND COMPLICATIONS (2014)[PG 121-RACE 2011]
 WHAT ARE THE CLINICAL FEATURES OF ORGANOPHOSPHOROUS POISONING?HOW
WILL YOU MANAGE A PATIENT OF ORAGNOPHOSPHOROUS POISONING IN ICU?(DEC
2012).

107) CO POISONING

 DISCUSS THE PATHOPHYSIOLOGY AND MANAGEMENT OF A CASE OF CARBON MONOX-

IDE POISONING(DEC 2008).[PG 1044 –MORGAN 4TH ED]
 DESCRIBE BRIEFLY PATHOPHYSIOLOGY,SIGNS,SYMPTOMS,DIAGNOSIS AND TREATMENT
OF CARBON DIOXIDE POISONING(DEC 2011)[PG 552-STOELTING]
 WRITE CLINICAL FEATURES,DIAGNOSIS AND MANAGEMENT OF A CASE OF PARACETA-
MOL POISONING(JUNE 2008).[PAUL MARINO]
 METHHEMOGLOBINEMIA AND ANAESTHETIST(JUNE 2008).
 DISCUSS THE SIGNS AND SYMPTOMS, PATHOPHYSIOLOGY AND MANAGEMENT OF CY-
ANIDE TOXICITY(JUNE 2012)(2017)

 CLINICAL FEATURES, DIAGNOSTIC CRITERIA AND MANAGEMENT OF SNAKE BITE POI-

SONING. (2016)

35
  A 65 YEAR OLD PATIENT,CHRONIC CIGARETTE SMOKER IS ADMITTED TO EMERGENCY
DEPARTMENT WITH ACUTE RESPIRATORY DISTRESS AND ALTERED SENSORIUM.HIS
ABG REVEALS PAO2 50 MMHG,PACO2 85 MMHG,PH-7.10.DISCUSS YOUR PLAN OF MAN-
AGEMENT(JUNE 2009).
 WHAT IS MIXED VENOUS OXYGEN SATURATION? AND ITS IMPORTANCE IN CRITICAL
CARE SETUP ? HOW IS IT MEASURED (DEC 2011). (2016)

CRITICAL CARE PROTOCOL.

MECHANICAL VENTILATION:-

108) WEANING

 WEANING MODES OF VENTILATION(JUNE 1997)(JUNE 2001)(DEC 2001)(DEC

2003,2006)[PG 1036-MORGAN]
 ENUMERATE THE PREDICTORS OF WEANING FROM MECHANICAL VENTILATION(JUNE
2009,2010,2012).[IJA 2006]
 HOW TO INITIATE A PATIENT ON MECHANICAL VENTILATION .
 INDICATIONS OF MECHANICAL VENTILATION IN THE POSTOPEARTIVE PERI-
OD(2014)(2015)

 RATIONALE AND INITIAL VENTILATORY SETTINGS IN A PT WITH OBSTRUCTIVE, RE-

STRICTIVE LUNG DISEASE (2016)
 PRINCIPLES AND ADVANTAGES OF DIFF TYPES OF JET VENTILATION, PRECAUTIONS TO
BE FOLLOWED (2016) (2017)

 OXYGEN THERAPY(DEC 1997)(DEC 1999).[PG 111-RACE 2009]

 NIV:ADVANTAGES,DISADVANTAGES AND METHODS OF ADMINISTRATION(JUNE
2007).[PG 73-RACE 2009,PG 315-ISACON 2009]DESCRIBE THE INTERFACES USED WITH
NIV , WHAT IS NIV PROTOCOL.DESCRIBE THE CURRENT DEFINITIVE INDICATION SOF
NIV (2014)
 WHAT IS OXYGEN DELIVERY ? CLASSIFY OXYGEN DELIVERY SYSTEMS. DISCUSS THE
ROLE OF VENTIMASK IN OXYGEN THERAPY(DEC 2011).
 MEASURES OF TISSUE OXYGENATION. DESCRIBE BRIEFLY OXYGEN DELIVERY , OXYGEN
CONSUMPTION AND OXYGEN EXTRACTION (2014)
 ROLE OF THE FOLLOWING IN A PATIENT OF SWINE FLU: A) EXTRA-CORPOREAL MEM-
BRANE OXYGENATOR (ECMO). B) HIGH FREQUENCY OSCILLATORY VENTILATION(2017

109) PEEP

36
  DESCRIBE PEEP,ITS MECHANISM OF ACTION,USES AND COMPLICATIONS(JUNE 2005).[PG
1037-MORGAN]
 DYNAMIC HYPERINFLATION AND PEEP .(2016)
 COMPARE AND CONTRAST PEEP AND CPAP(DEC 2008).[PG 1038-MORGAN 4TH ED]
 WHAT IS PEEP? HOW DOES IT IMPROVE ARTERIAL PO2?WHAT ARE ITS DISAD-
VANTAGES?(DEC 2011)

110) ARDS

 BERLINS DEFINITION OF ARDS, ETIOPATHOGENESIS, SEVERITY CLASSIFICATION AND

MGT(1997, 2015)
 DESCRIBE THE PATHOPHYSIOLOGY OF ARDS.WHAT ARE THE DIAGNOSTIC CRITE-
RIA(DEC 1997).[PH 143-RACE 2012]
 DESCRIBE THE VENTILATORY MANAGEMENT OF ARDS(DEC 2005)(DEC 2010).[PG 669-
SATISH DESHPANDE][PG 1042-MORGAN 4TH ED](2008)
 RECENT ADVANCES IN THE MANAGEMENT OF ALI AND ARDS(JUNE 2007).
 DEFINE AND CLASSIFY RESPIRATORY FAILURE.(2016)
 PERMISSIVE HYPERCAPNIA(JUNE 2008). (JUNE 2010). .(2016)

111) ANALGESIA /SEDATION/PARALYSIS

 ENUMERATE THE ROLE OF ANALGESICS AND SEDATION IN PATIENTS ON VENTILATOR

THERAPY IN ICU(JUNE 2009)
 DIFFERENT MEASURES USED TO ASSESS SEDATION IN ICU. BRIEFLY DESCRIBE THREE
COMMONLY USED AGENTS FOR ICU SEDATION. (2015)(2014)
 CURRENT OPINION ON PAIN MGT IN ICU (2014)
 CLOSED SUCTION CATHETER FOR TRACHEAL SUCTIONING (2016)

 MGT OF A PT WITH ELECTRIC SHOCK (2016)

 ROLE OF AIRWAY EXCHANGE CATHETERS IN MODERN ANAESTHESIA PRACTICE (2014)

112) SEPSIS

 DEFINE AND CLASSIFY SHOCK, GUIDELINES FOR MGT OF CARDIOGENIC SHOCK

(2013)(2011)
 ENUMERATE THE SYMPTOMS OF SHOCK AND DISCUSS THE METHODS USED FOR AS-
SESSMENT OF SYSTEMIC PERFUSION(JUNE 2008).(2016)

37
  DESCRIBE VARIOUS COMPONENTS OF SURVIVING SEPSIS GUIDELINES(DEC 2010).(2012)
 HOW WOULD YOU ASSESS A CASE OF SEPTIC SHOCK DUE TO PANCREATITIS?BRIEFLY
DISCUSS ITS MANAGEMENT(JUNE 2012)
 WHAT ARE THE COMMON NOSOCOMIAL INFECTIONS IN ICU?DISCUSS THE MEASURES
FOR PREVENTION OF VAP(JUNE 2009)(2001).
 WHAT ARE THE CRITERIA FOR DIAGNOSIS OF SIRS? DISCUSS THE PRINCIPLES OF MAN-
AGEMENT IN A PATIENT OF SEPTIC SHOCK ADMITTED IN AN ICU(DEC 2006).(2013)

 DEFINE ‘CRUSH SYNDROME’. PATHOGENESIS OF SHOCK AND ACUTE RENAL FAILURE IN

CRUSH SYNDROME. HOW WILL YOU MANAGE SUCH A CASE? (2016)

113) BLOOD LOSS

 WRITE AN ALGORITHM FOR THE MANAGEMENT OF EARLY HAEMORRHAGIC SHOCK.

WHAT ARE THE GOALS IN EARLY RESUSCITATION DURING ACTIVE BLEEDING?(DEC
2012) .
 GOALS ADVANTAGES AND DISADVANTAGES OF EARLY AND LATE RESUSCITA-
TION.(2013)
 INDICATIONS OF PERMISSIVE HYPOTENSION (2014), FLUID MGT IN HEMORRHAGIC
SHOCK (2014)
 A 26 YEAR OLD, ASA GRADE I MALE WEIGHING 75 KG WAS POSTED FOR SURGERY FOR
FRACTURE SHAFT OF FEMUR. HIS PRE-OPERATIVE HB WAS 13 GM% AND HE BLED 850
ML DURING THE SURGERY: A) WHAT SHOULD BE THE TRANSFUSION TRIGGER HEMATO-
CRIT FOR BLOOD TRANSFUSION IN THIS PATIENT? B) HOW WOULD YOU CALCULATE AL-
LOWABLE BLOOD LOSS IN THIS PATIENT? C) WHAT ARE THE METHODS OF REDUCING
INTRA-OPERATIVE BLOOD LOSS?(2017)

 COAGULATION ABNORMALITIES THAT CAN OCCUR IN HAEMORRHAGIC SHOCK. HOW

WILL YOU INVESTIGATE AND TREAT IT? (2015)
 DESCRIBE CLASSICAL COAGULATION CASCADE. METHODS OF PERIOPERATIVE COAGU-
LATION TESTING (2015)
 DESCRIBE THE ALGORITHM OF THE EVALUATION AND INITIAL THERAPY OF A PATIENT
WITH SUSPECTED PERIOPERATIVE COAGULOPATHY(DEC 2012,2011).
 WHAT IS DIC ?ENUMERATE ITS CAUSES AND MANAGEMENT(JUNE 2009,1995,1998)[PG
403-BARASCH 6TH ED] (2017)
 WHAT IS TEG? DRAW A LABELED DIAGRAM TO SHOW A NORMAL TRACING.WHAT ARE
ITS IMPLICATIONS?(DEC 2008).[PG 394-BARASCH 6TH ED,PG 338-YAO]

38
114) BLOOD COMPONENT THERAPY

 STEPS FOR SEPARATION OF WHOLE BLOOD INTO VARIOUS COMPONENTS(2015)

 BLOOD COMPONENT THERAPY(DEC 1998)(JUNE 2002)(JUNE 2005,2007)[PG 161 ISACON
2008,PG 1758-MILLER]
 ENUMERATE THE INDICATIONS FOR TRANSFUSION OF PACKED RED
CELLS,FFP,PLATELETS AND CRYOPRECIPITATES(JUNE 2010) (2015)

 COMPLICATIONS AND SEQUELAE OF BT(JUNE 1996)(DEC 2008,2003,)[PG 700-MORGAN

4TH ED]
 HOW WILL YOU DIAGNOSE MISMATCHED BT INTRAOPERATIVELY?DESCRIBE ITS MAN-
AGEMENT(DEC 2009).
 DEFINE MASSIVE BT.DISCUSS THE COMPLICATIONS ASSOCIATED WITH MASSIVE BLOOD
TRANSFUSION(JUNE 2009,2011).

 RECENT TRENDS OF BT AND BLOOD PRODUCTS(1996-2000).[PG 147-RACE 2011]

 WHAT IS AUTOLOGOUS BT? DISCUSS CRITERIA FOR PATIENT SELEC-
TION,CONTRAINDICATIONS,ADVANTAGES AND DISADVANTAGES OF AUTOLOGOUS
BT(JUNE 2012).(DEC 2006,2007,2012) .[PG 151-RACE 2011][PG 1781-MILLER]

 WHAT ARE THE METHODS ADOPTED BY THE ANAESTHETIST TO REDUCE THE NEED
FOR ALLOGENIC BLOOD TRANSFUSIONS(JUNE 2005,2010).
 WRITE THE BLOOD CONSERVATION STRATEGIES IN A 20 YEAR OLD FEMALE SCHED-
ULED FOR EXCISION OF ANGIOFIBROMA OF NOSE(JUNE 2008).[PG 65-RACE 2009]

115) BURNS

 DISCUSS THE MANAGEMENT OF A CASE OF 40% BURNS(JUNE 1997).[PG 49,RACE 2011]

 MANAGEMENT OF AN ADULT WITH SMOKE INHALATIONAL INJURY(DEC 2004)
 ENUMERATE THE ANTICIPATED PROBLEMS IN AN ADULT PATIENT WITH: 2 DAYS OLD
SMOKE INHALATIONAL INJURY.(2016)
 RESUSCITATION OF A PATIENT WITH 60% DEEP BURN INJURY(DEC 2000) (JUNE 2009)[
[PG 59-RACE 2007]

116) TRACHEOSTOMY

 PERCUTANEOUS DILATATIONAL TRACHEOSTOMY: INDICATIONS , TECHNIQUES AND COMPLICA-

TIONS(JUNE 2009).[IJA 2008-52(1)] (2016),2010,2015) PG 237-RACE 2009

117) NUTRITION AND METABOLIC CONTROL.

39
  METABOLIC CHANGES THAT OCCUR DURING CRITICAL ILLNESS. GOALS OF NUTRI-
TIONAL SUPPORT IN CRITICALLY ILL PATIENTS. ENUMERATE THE DAILY REQUIRE-
MENTS FOR A CRITICALLY ILL PATIENT ADMITTED IN I C U.
 WHAT ARE THE GOALS OF NUTRITIONAL SUPPORT IN CRITICALLY ILL PA-
TIENTS?DESCRIBE THE DAILY REQUIREMENTS FOR PROTEINS,LIPIDS,CARBOHYDRATES
FOR A PATIENT WITH ADVANCED SEPSIS ADMITTED IN THE ICU(JUNE 2011).
 HOW WILL YOU CALCULATE THE ENERGY REQUIREMENTS IN AN ICU PATIENT?WHAT
ARE THE ADVANTAGES AND DISADVANTAGES OF PARENTERAL VERSUS ENTERAL NU-
TRITION?(DEC 2012).CONTRAINDIACTIONS OF PARENTERAL NUTRITION IN ICU (2016)
 ENTERAL FEEDING IN THE CRITICALLY ILL PATIENTS-INDICATIONS,TECHNIQUES AND
COMPLICATIONS(JUNE 2010,2008)
 HOW WOULD YOU GIVE TPN TO 50 KG PERSON IN ICU. MONITORING THE PATIENT ON
TPN. (2015) .(2013)
 SPECIAL CONSIDERATIONS IN NUTRITION IN A PT WITH RENAL DYSFUNCTION (2016)
 REFFEDING SYNDROME (2016)

CPR-BLS AND ALS.

118) NEONATAL RESUSCITATION

 WHAT ARE THE RECENT GUIDELINES FOR NEONATAL RESUSCITATION(DEC 2008)
.(2013)
 WHAT ARE THE NEW GUIDELINES FOR VENTILATION AND EXTERNAL CARDIAC COM-
PRESSION FOR NEONATAL RESUSCITATION?WHAT ARE THE DRUGS(WITH DOSES) USED
FOR NEONATAL RESUSCITATION?(JUNE 2011). [IJA 2010].(2015)
 WRITE DOWN THE ALGORITHM FOR RESUSCITATION OF A NEWBORN(DEC 2012)

 ENUMERATE 5 H’S AND 5 T’S AS POSSIBLE CAUSES OF CARDIAC ARREST.WHAT IT THE

MANAGEMENT OF PEA IN AN UNCONSCIOUS PATIENT?(DEC 2008,2010).
 ENUMERATE THE CHANGES IN THE ACC/AHA GUIDELINES ON RESUSCITATION(BLS
&ACLS) FOR MANAGEMENT OF CARDIAC ARREST IN ADULT(JUNE 2010)
 DESCRIBE THE PHYSIOLOGY OF CIRCULATION DURING CLOSED CHEST COMPRESSIONS.
DISCUSS THE ALGORITHM FOR BLS(DEC 2011)
 DESCRIBE THE OBJECTIVES AND INITIAL ASSESSMENT OF AN ADULT ROADSIDE TRAU-
MA VICTIM PRESNTING TO THE EMERGENCY DEPARTMENT.(2013)
 POST RESUSCITATION CARE IN A PATIENT REVIVED AFTER CARDIORESPIRATORY
CARE.(2016)

40
  CONCEPT OF INDUCED HYPOTHERMIA AFTER CARDIAC ARREST , COMPLICATIONS OF
HYPOTHERMIA IN A PATIENT WITH POLYTRAUMA (2014)
 END POINT OF RESUSCITATION IN ICU (2014)
 MANAGEMENT OF A DECEASED DONOR IN ICU (2014)

119) BRAIN DEATH.

WRITE IN BRIEF THE CRITERIA FOR DETERMINATION OF BRAIN DEATH AND CLINICAL TESTS FOR CON-
FIRMATION (DEC 2008).[PG 567-ISACON 2009](2013) AND GOALS OF ANAESTEHSIA IN ORGAN HARVEST-
ING(JUNE 2010).(2015)

120) STATISTICAL METHODS IN ANAESTHESIA.

 WHAT DO YOU UNDERSTAND BY RANDOMIZATION AND BLINDING IN A CLINICAL
STUDY?WHAT IS IMPORTANCE OF P-VALUE AND POWER OF STUDY?(DEC 2010).
 SENSITIVITY ANS SPECIFICITY AS DIAGNOSTIC STATISTICAL TEST (2014)
 DIFFERENTIATE BETWEEN PARAMETRIC AND NON PARAMETRIC TESTS OF SIGNIFI-
CANCE.(2016)
 WHAT IS NORMAL DISTRIBUTION ,DIFF B/W PAIRED AND UNPAIRED STUDENT T TEST ?
HOW ARE TWO PROPORTIONS COMPARED BETWEEN INDEPENDENT SAMPLES (2014)
 DIFFERENTIATE BETWEEN STANDARD DEVIATION AND STANDARD ERROR IN CASE OF
QUANTITIVE DATA.(2016) (2017)
 AGENTS USED FOR CHEMICAL DISINFECTION AND STERLIZATION. FACTORS INFLUENC-
ING THEM , ADVANTAGES AND DISADVANTAGES OF EACH (2015)
 2. A) GUIDELINES FOR BIOMEDICAL WASTE MANAGEMENT. (2016)
 B) GLOBAL WARMING AND OZONE DEPLETION EFFECT BY INHALATIONAL ANAESTHET-
IC AGENTS.
 C) PRE-CONDITIONING BY VOLATILE ANAESTHETIC AGENTS.
 4 DESCRIBE HOW GLYCEMIC CONTROL AFFECTS THE OUTCOME IN CRITICALLY ILL PA-
TIENTS.DESCRIBE THE ADVANTAGES AND DISADVANTAGES OF TIGHT AND NON
TIGHT GLYCEMIC CONTROL IN ICU.(2013)
 PREOPERATIVE EVALUATION, PREPARATION AND MANAGEMENT OF A 20 YEAR OLD
MALE WITH HISTORY OF SUBSTANCE ABUSE SCHEDULED FOR LAPAROTOMY.(2015)

o ETIOLOGY AND CLINICAL MANIFESTATIONS OF ACUTE GUILLAIN BARRÉ SYN-

DROME.
o IMPORTANT CONSIDERATIONS WHILE INTUBATING A PATIENT WITH ACUTE
GUILLAIN BARRÉ SYNDROME IN THE WARD.(2016)

41
  ANAESTHETIC IMPLICATIONS IN A PATIENT WITH SICKLE CELL DISEASE, COMING FOR
SURGERY. (2016)
 NEUROPLASTICITY DEFINITION, DRUGS AND TECHNIQUES THAT CAN PREVENT AND
TREAT IT (2014)
 WHAT IS CENTRAL SENSITIZATION STRATEGIES USED TO PREVENT AND TREAT IT
(2014)
 NITRIC OXIDE CURRENT STATUS(DEC 1995)(JUNE 2010)2008.

121) MISCELL

 ENUMERATE GENERAL PRINCIPLES OF ANAESTHESIA OUTSIDE THE OPERATING

ROOM.BRIEFLY OUTLINE THE ANAESTHETIC PLAN FOR 23 YR OLD PT PLANNED FOR
OOCYTE RETRIEVAL IN IVF SUITE (2013)
 WHAT ARE THE LIMITATIONS AND HAZARDS OF PROVIDING ANAESTHESIA IN THE MRI
SUITE?DESCRIBE THE ANAESTHETIC MANAGEMENT OF A 6 MONTHS OLD CHILD WITH
HYDROCEPHALUS SCHEDULED FOR MRI(DEC 2009)(DEC 2012). (2015)
 DESCRIBE THE ANAESTHETIC MANAGEMENT IN A PATIENT SCHEDULED FOR MRI(DEC
2010).
 OVARIAN HYPERSTIMULATION SYNDROME, CLINICAL FEATURES AND TRETA-
MENT(2017)
 PATHOPHYSIOLOGY AND MANAGEMENT OF DROWNING PATIENT.(2017)

42